<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32635522</article-id><article-id pub-id-type="pmc">7411736</article-id><article-id pub-id-type="doi">10.3390/molecules25133062</article-id><article-id pub-id-type="publisher-id">molecules-25-03062</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Effects of Sesamin, the Major Furofuran Lignan of Sesame Oil, on the Amplitude and Gating of Voltage-Gated Na<sup>+</sup> and K<sup>+</sup> Currents</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3019-1138</contrib-id><name><surname>Kuo</surname><given-names>Ping-Chung</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03062">1</xref></contrib><contrib contrib-type="author"><name><surname>Kao</surname><given-names>Zi-Han</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03062">2</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Shih-Wei</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03062">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5208-3253</contrib-id><name><surname>Wu</surname><given-names>Sheng-Nan</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03062">2</xref><xref ref-type="aff" rid="af3-molecules-25-03062">3</xref><xref ref-type="aff" rid="af4-molecules-25-03062">4</xref><xref rid="c1-molecules-25-03062" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-molecules-25-03062"><label>1</label>School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan; <email>z10502016@email.ncku.edu.tw</email></aff><aff id="af2-molecules-25-03062"><label>2</label>Department of Physiology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan; <email>s36084062@ncku.edu.tw</email> (Z.-H.K.); <email>s36081048@ncku.edu.tw</email> (S.-W.L.)</aff><aff id="af3-molecules-25-03062"><label>3</label>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan</aff><aff id="af4-molecules-25-03062"><label>4</label>Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan</aff><author-notes><corresp id="c1-molecules-25-03062"><label>*</label>Correspondence: <email>snwu@mail.ncku.edu.tw</email>; Tel.: +886-6-235-3535-5334; Fax: +886-6-2362780</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2020</year></pub-date><volume>25</volume><issue>13</issue><elocation-id>3062</elocation-id><history><date date-type="received"><day>27</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Sesamin (SSM) and sesamolin (SesA) are the two major furofuran lignans of sesame oil and they have been previously noticed to exert various biological actions. However, their modulatory actions on different types of ionic currents in electrically excitable cells remain largely unresolved. The present experiments were undertaken to explore the possible perturbations of SSM and SesA on different types of ionic currents, e.g., voltage-gated Na<sup>+</sup> currents (<italic>I</italic><sub>Na</sub>), <italic>erg</italic>-mediated K<sup>+</sup> currents (<italic>I</italic><sub>K(erg)</sub>), M-type K<sup>+</sup> currents (<italic>I</italic><sub>K(M)</sub>), delayed-rectifier K<sup>+</sup> currents (<italic>I</italic><sub>K(DR)</sub>) and hyperpolarization-activated cation currents (<italic>I</italic><sub>h</sub>) identified from pituitary tumor (GH<sub>3</sub>) cells. The exposure to SSM or SesA depressed the transient and late components of <italic>I</italic><sub>Na</sub> with different potencies. The IC<sub>50</sub> value of SSM needed to lessen the peak or sustained <italic>I</italic><sub>Na</sub> was calculated to be 7.2 or 0.6 &#x003bc;M, while that of SesA was 9.8 or 2.5 &#x003bc;M, respectively. The dissociation constant of SSM-perturbed inhibition on <italic>I</italic><sub>Na</sub>, based on the first-order reaction scheme, was measured to be 0.93 &#x003bc;M, a value very similar to the IC<sub>50</sub> for its depressant action on sustained <italic>I</italic><sub>Na</sub>. The addition of SSM was also effective at suppressing the amplitude of resurgent <italic>I</italic><sub>Na</sub>. The addition of SSM could concentration-dependently inhibit the <italic>I</italic><sub>K(M)</sub> amplitude with an IC<sub>50</sub> value of 4.8 &#x003bc;M. SSM at a concentration of 30 &#x003bc;M could suppress the amplitude of <italic>I</italic><sub>K(erg)</sub>, while at 10 &#x003bc;M, it mildly decreased the <italic>I</italic><sub>K(DR)</sub> amplitude. However, the addition of neither SSM (10 &#x003bc;M) nor SesA (10 &#x003bc;M) altered the amplitude or kinetics of <italic>I</italic><sub>h</sub> in response to long-lasting hyperpolarization. Additionally, in this study, a modified Markovian model designed for <italic>SCN8A</italic>-encoded (or Na<sub>V</sub>1.6) channels was implemented to evaluate the plausible modifications of SSM on the gating kinetics of Na<sub>V</sub> channels. The model demonstrated herein was well suited to predict that the SSM-mediated decrease in peak <italic>I</italic><sub>Na</sub>, followed by increased current inactivation, which could largely account for its favorable decrease in the probability of the open-blocked over open state of Na<sub>V</sub> channels. Collectively, our study provides evidence that highlights the notion that SSM or SesA could block multiple ion currents, such as <italic>I</italic><sub>Na</sub> and <italic>I</italic><sub>K(M)</sub>, and suggests that these actions are potentially important and may participate in the functional activities of various electrically excitable cells in vivo.</p></abstract><kwd-group><kwd>sesamin</kwd><kwd>sesamolin</kwd><kwd>Na<sup>+</sup> current</kwd><kwd>M-type K<sup>+</sup> current</kwd><kwd><italic>erg</italic>-mediated K<sup>+</sup> current</kwd><kwd>current kinetics</kwd><kwd>simulation model</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-03062"><title>1. Introduction</title><p>Sesame seeds and sesame oil have been widely recognized as health foods in Asian countries [<xref rid="B1-molecules-25-03062" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-03062" ref-type="bibr">2</xref>]. In comparison with other edible oils extracted from diverse seeds, sesame oil is extremely stable, possibly due to the effective antioxidant activities presumably attributed to its abundance of lipid-soluble furofuran lignans, such as sesamin (SSM) and sesamolin (SesA) [<xref rid="B3-molecules-25-03062" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-03062" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-03062" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-03062" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-03062" ref-type="bibr">7</xref>]. Emerging research has previously demonstrated that SSM and SesA, the two major furofuran lignans of sesame oil, are able to suppress lipid peroxidation in erythrocytes [<xref rid="B8-molecules-25-03062" ref-type="bibr">8</xref>], to inhibit the intestinal absorption of cholesterol and hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity [<xref rid="B9-molecules-25-03062" ref-type="bibr">9</xref>], to prevent chemically induced mammary cancer, to inhibit D<sup>5</sup>-desaturase and the chain elongation of C18 fatty acids [<xref rid="B10-molecules-25-03062" ref-type="bibr">10</xref>], and to protect hypoxic neuronal and PC12 cells by suppressing ROS generation and MAPK activation [<xref rid="B11-molecules-25-03062" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-03062" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-03062" ref-type="bibr">13</xref>], as well as to exhibit antihypertensive or cardioprotective effects [<xref rid="B1-molecules-25-03062" ref-type="bibr">1</xref>,<xref rid="B3-molecules-25-03062" ref-type="bibr">3</xref>,<xref rid="B14-molecules-25-03062" ref-type="bibr">14</xref>]. Earlier reports have revealed that either probucol or the triterpenoid fraction of <italic>Ganoderma</italic>, known to possesses the antioxidant activity, could perturb the activity of ionic currents in pituitary lactotrophs [<xref rid="B15-molecules-25-03062" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-03062" ref-type="bibr">16</xref>]. However, whether these therapeutic lignans (e.g., SSM, SesA) can directly perturb the activity of membrane ion currents is largely uncertain.</p><p>Molecular studies of epileptogenesis have revealed that specific ion channels play essential roles in both genetic and acquired forms of epilepsy, particularly voltage-gated Na<sup>+</sup> (Na<sub>V</sub>) channels [<xref rid="B17-molecules-25-03062" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-03062" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-03062" ref-type="bibr">19</xref>,<xref rid="B20-molecules-25-03062" ref-type="bibr">20</xref>,<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>]. Nine isoforms (Na<sub>V</sub>1.1&#x02013;1.9) are found in mammalian excitable tissues, including the central nervous system, peripheral nervous system, endocrine system, skeletal muscles, and heart [<xref rid="B22-molecules-25-03062" ref-type="bibr">22</xref>]. Moreover, several inhibitors known to preferentially block the late component of voltage-gated Na+ currents (<italic>I</italic><sub>Na</sub>), such as ranolazine, eugenol, and perampanel, have been reported to suppress seizure activity [<xref rid="B23-molecules-25-03062" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-03062" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-03062" ref-type="bibr">25</xref>]. However, whether SSM or SesA are capable of exerting any perturbation on the amplitude and gating of <italic>I</italic><sub>Na</sub> in response to rapid membrane depolarization remains poorly understood, though SSM was previously noted to activate transient receptor potential vanilloid type 1 in endothelial cells [<xref rid="B26-molecules-25-03062" ref-type="bibr">26</xref>]. Alternatively, the presence of SSM has been previously revealed to suppress damage or apoptosis by streptozotocin in endocrine cells [<xref rid="B27-molecules-25-03062" ref-type="bibr">27</xref>,<xref rid="B28-molecules-25-03062" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-03062" ref-type="bibr">29</xref>].</p><p>For the reasons described above, the goal of the present study was to explore whether SSM and SesA could exert any perturbations on different types of ionic currents (e.g., <italic>I</italic><sub>Na</sub>) present in pituitary GH<sub>3</sub> cells. The biophysical and pharmacological properties of ionic currents, including voltage-gated <italic>I</italic><sub>Na</sub>, resurgent <italic>I</italic><sub>Na</sub> (<italic>I</italic><sub>Na(R)</sub>), M-type K<sup>+</sup> currents (<italic>I</italic><sub>K(M)</sub>), erg-mediated K<sup>+</sup> currents (<italic>I</italic><sub>K(erg)</sub>), delayed-rectifier K<sup>+</sup> currents (<italic>I</italic><sub>K(DR)</sub>) and hyperpolarization-activated cation currents (<italic>I</italic>), were extensively studied in these cells. Moreover, the present work aimed to use a mathematical modeling approach for the evaluation of the perturbating actions on Na<sub>V</sub>-channel kinetics caused by SSM. The findings from the present observations highlight the notion that the furofuran lignans, such as SSM and SesA, are capable of perturbing the amplitude of <italic>I</italic><sub>Na</sub> effectively in a concentration-, time-, and state-dependent manner.</p></sec><sec sec-type="results" id="sec2-molecules-25-03062"><title>2. Results</title><sec id="sec2dot1-molecules-25-03062"><title>2.1. Inhibitory Effect of Sesamin (SSM) on Voltage-Gated Na<sup>+</sup> Currents (I<sub>Na</sub>) Identified in GH<sub>3</sub> Cells</title><p>In an initial step of the experiments, we examined the effects of SSM on the amplitude and gating of <italic>I</italic><sub>Na</sub> in response to rapid membrane depolarization. Cells were bathed in Ca<sup>2+</sup>-free Tyrode&#x02019;s solution containing 10 mM tetraethylammonium chloride (TEA) and the recording pipette was backfilled with a Cs<sup>+</sup>-containing solution. As illustrated in <xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>A, after 1 min of exposing cells to 3 or 10 &#x003bc;M SSM, the amplitude in the peak and sustained component of <italic>I</italic><sub>Na</sub> elicited by rapid membrane depolarization from &#x02212;80 mV was evidently decreased. For example, when rapid membrane depolarization from &#x02212;80 to &#x02212;10 mV with a duration of 40 msec was delivered (indicated in the inset of <xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>A) to evoke <italic>I</italic><sub>Na</sub> [<xref rid="B30-molecules-25-03062" ref-type="bibr">30</xref>], the addition of 3 &#x003bc;M SSM caused a decrease in the peak or sustained amplitude of <italic>I</italic><sub>Na</sub> to 139 &#x000b1; 11 pA (n = 11, <italic>P</italic> &#x0003c; 0.05) or 12 &#x000b1; 3 pA (n = 11, <italic>P</italic> &#x0003c; 0.05), respectively, from the control values of 248 &#x000b1; 18 or 21 &#x000b1; 2 pA (n = 11). After the removal of SSM, the peak and sustained amplitude returned to 232 &#x000b1; 16 or 19 &#x000b1; 2 pA (n = 7, <italic>P</italic> &#x0003c; 0.05).</p><p><xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>B illustrates that the presence of SSM can concentration-dependently depress the amplitude of peak or sustained <italic>I</italic><sub>Na</sub> activated during rapid membrane depolarization. The IC<sub>50</sub> value needed for the SSM-perturbed decrease of peak or sustained <italic>I</italic><sub>Na</sub> identified in GH<sub>3</sub> cells was 7.2 or 0.6 &#x003bc;M, respectively, the value of which was noticed to be distinct significantly between its effects on these two components. The obtained results thus demonstrate that SSM has a depressant action on the peak or sustained <italic>I</italic><sub>Na</sub> functionally expressed in GH<sub>3</sub> cells.</p></sec><sec id="sec2dot2-molecules-25-03062"><title>2.2. Kinetic Constants of I<sub>Na</sub> Block by SSM</title><p>During cell exposure to SSM, the <italic>I</italic><sub>Na</sub> in response to brief depolarization exhibited a decline in peak amplitude followed by a rise in the exponential decay of the current. For this reason, it would thus be critical to gain information about the kinetics of the SSM-induced block of these currents observed in these cells. The concentration dependence of <italic>I</italic><sub>Na</sub> decay (i.e., current inactivation) during a brief depolarization caused by the presence of SSM was derived and is illustrated in <xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>C. It is important to emphasize that the effect of SSM on <italic>I</italic><sub>Na</sub> resulted in a concentration-dependent rise in the rate of current decay, as well as in a considerable decrease in the sustained current, notwithstanding its ineffectiveness in perturbing the initial activation phase of <italic>I</italic><sub>Na</sub> responding to brief depolarizing pulse. In other words, increasing the SSM concentration not only caused a reduction in the peak amplitude of <italic>I</italic><sub>Na</sub>, but also remarkably enhanced the inactivation rate of the current in response to abrupt membrane depolarization. It stands to reason, therefore, that the inhibitory effect of SSM on <italic>I</italic><sub>Na</sub> identified from GH<sub>3</sub> cells can be reflected with a state-dependent blocker which binds favorably to the open state of the Na<sub>V</sub> channel according to a minimal binding scheme, given as follows:<disp-formula id="FD1-molecules-25-03062"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:munderover><mml:mo stretchy="true">&#x021c4;</mml:mo><mml:mi mathvariant="sans-serif">&#x003b2;</mml:mi><mml:mi mathvariant="sans-serif">&#x003b1;</mml:mi></mml:munderover><mml:mi mathvariant="normal">O</mml:mi><mml:munderover><mml:mo stretchy="true">&#x021c4;</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>&#x022c5;</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi>SSM</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:munderover><mml:mi mathvariant="normal">O</mml:mi><mml:mo>&#x022c5;</mml:mo><mml:mi>SSM</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
where &#x003b1; and &#x003b2; is the kinetic constant for the opening or closing of the Na<sub>V</sub> channel, <italic>k</italic><sub>+1</sub><sup>*</sup>&#x000b7;[SSM] and <italic>k</italic><sub>&#x02212;1</sub> represents the block (forward) or unblock (backward) caused by the presence of SSM, [SSM] is the blocker (i.e., SSM) concentration, and C, O, and O&#x000b7;SSM shown in the scheme are the closed (resting), open, and open-blocked states, respectively.</p><p>The block or unblock rate constant (i.e., <italic>k</italic><sub>+1</sub><sup>*</sup>&#x000b7;[SSM] and <italic>k</italic><sub>&#x02212;1</sub>) was determined from the value (i.e., &#x003c4;<sub>inact(S)</sub>) of the slow component of the <italic>I</italic><sub>Na</sub> inactivation time constant during cell exposure to different SSM concentrations (<xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>C), while SSM presence did not alter the fast component of the <italic>I</italic><sub>Na</sub> inactivation time course. Because a Hill coefficient of approximately 1 was obtained from the concentration&#x02013;response curve, the block or unblock rate constant achieved in this study was evaluated using the formula given as follows:<disp-formula id="FD2-molecules-25-03062"><label>(2)</label><mml:math id="mm2"><mml:mrow><mml:mrow><mml:msup><mml:msub><mml:mi mathvariant="sans-serif">&#x003c4;</mml:mi><mml:mrow><mml:mi>inact</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">S</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>&#x000b7;</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>SSM</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>In this formula, the parameter value of <italic>k</italic><sub>+1</sub><sup>*</sup> (the slope) and <italic>k</italic><sub>-1</sub> (the intercept) was calculated. As predicted from this minimum binding scheme, the relationship between 1/&#x003c4;<sub>inact(S)</sub> and [SSM] became linear with a correlation coefficient of 0.97 (<xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>C). The resultant rate constant of blocking or unblocking perturbed by the addition of SSM was calculated to be 0.0449 msec<sup>&#x02212;1</sup>&#x003bc;M<sup>&#x02212;1</sup> or 0.0415 msec<sup>&#x02212;1</sup>, respectively; as a consequence, a value of 0.93 &#x003bc;M for the dissociation constant (<italic>K</italic><sub>D</sub> = <inline-formula><mml:math id="mm3"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>&#x000b7;</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>SSM</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>) of SSM could be achieved.</p><p>We also further examined effects of SSM on peak <italic>I</italic><sub>Na</sub> measured at different levels of membrane potential. As shown in <xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>D, the experimental observations revealed that the overall current&#x02013;voltage (<italic>I-V</italic>) relationship of peak <italic>I</italic><sub>Na</sub> attained between the absence and presence of 3 &#x003bc;M SSM did not differ noticeably, though the peak amplitude of the current measured at the level of each voltage was significantly decreased in the presence of SSM.</p></sec><sec id="sec2dot3-molecules-25-03062"><title>2.3. Comparison Between Effects of SSM, SesA, SSM Plus Tefluthrin, and SSM Plus Telmisartan on Peak I<sub>Na</sub> Identified in GH<sub>3</sub> Cells</title><p>In another experiment, we tested the effects of SSM, sesamolin (SesA), SSM plus tefluthrin, and SSM plus telmisartan on the peak amplitude of <italic>I</italic><sub>Na</sub> responding to rapid membrane depolarization to &#x02212;10 mV from a holding potential of &#x02212;80 mV. Tefluthrin, a type I pyrethroid insecticide, and telmisartan, a blocker of angiotensin II receptors, were previously demonstrated to activate <italic>I</italic><sub>Na</sub> directly and effectively [<xref rid="B20-molecules-25-03062" ref-type="bibr">20</xref>,<xref rid="B30-molecules-25-03062" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-03062" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-03062" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-03062" ref-type="bibr">33</xref>]. As shown in <xref ref-type="fig" rid="molecules-25-03062-f002">Figure 2</xref>, SSM or SesA, at a concentration of 3 &#x003bc;M, produced inhibitory effects on the peak amplitude of <italic>I</italic><sub>Na</sub>. Furthermore, in the continued presence of SSM (3 &#x003bc;M), the subsequent addition of either tefluthrin (10 &#x003bc;M) or telmisartan (10 &#x003bc;M) was effective in reversing the SSM-induced inhibition of peak <italic>I</italic><sub>Na</sub>.</p></sec><sec id="sec2dot4-molecules-25-03062"><title>2.4. Concentration-Dependent Inhibition of I<sub>Na</sub> Caused by Sesamolin (SesA)</title><p>The effects of SesA, another furofuran lignan, on <italic>I</italic><sub>Na</sub> in response to an abrupt depolarizing pulse were further examined and compared in this study. The concentration-dependent relationships among the inhibitory effects of SesA on the peak and sustained component of <italic>I</italic><sub>Na</sub> are illustrated in <xref ref-type="fig" rid="molecules-25-03062-f003">Figure 3</xref>. The IC<sub>50</sub> value of SesA required for its effect on the peak or sustained <italic>I</italic><sub>Na</sub> measured at the beginning or end of a brief depolarizing pulse was calculated to be 9.8 and 2.5 &#x003bc;M, respectively, though these values were relatively higher than for the SSM used for the blocking of the peak or sustained <italic>I</italic><sub>Na</sub> in GH<sub>3</sub> cells.</p></sec><sec id="sec2dot5-molecules-25-03062"><title>2.5. Inhibitory Effect of SSM on Resurgent I<sub>Na</sub> (I<sub>Na(R)</sub>) in GH<sub>3</sub> Cells</title><p>We next wanted to determine whether SSM exerts any effects on <italic>I</italic><sub>Na(R)</sub> identified from these cells [<xref rid="B30-molecules-25-03062" ref-type="bibr">30</xref>]. The whole-cell experiments on <italic>I</italic><sub>Na(R)</sub> were undertaken when each cell was voltage clamped at &#x02212;80 mV and a brief depolarizing step to +20 mV was delivered to activate transient <italic>I</italic><sub>Na</sub>. The <italic>I</italic><sub>Na(R)</sub> upon repolarization to various potentials ranging between &#x02212;50 and 0 mV was thereafter measured at the end of voltage pulses (<xref ref-type="fig" rid="molecules-25-03062-f004">Figure 4</xref>). The effect of SSM on <italic>I</italic><sub>Na(R)</sub> was examined at various membrane potentials, and the <italic>I-V</italic> relationship of <italic>I</italic><sub>Na(R)</sub> with or without the addition of SSM was constructed. The presence of SSM (1 &#x003bc;M) was capable of decreasing <italic>I</italic><sub>Na(R)</sub> with no noticeable change in its voltage dependence in GH<sub>3</sub> cells, since the overall shape of the <italic>I&#x02013;V</italic> curves for <italic>I</italic><sub>Na(R)</sub> appearing between the absence and presence of SSM appeared to be similar. For example, at the level of &#x02212;30 mV, the exposure to 1 &#x003bc;M SSM resulted in a decrease in <italic>I</italic><sub>Na(R)</sub> amplitude from 46 &#x000b1; 6 to 22 &#x000b1; 5 pA (n = 8, <italic>P</italic> &#x0003c; 0.05).</p></sec><sec id="sec2dot6-molecules-25-03062"><title>2.6. Concentration-Dependent Inhibition of M-Type K<sup>+</sup> Currents (I<sub>K(M)</sub>) Caused by SSM in GH<sub>3</sub> Cells</title><p>The following experiments were further undertaken to determine whether the addition of SSM could exert any perturbations on the amplitude or gating of <italic>I</italic><sub>K(M)</sub> in these cells [<xref rid="B34-molecules-25-03062" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-03062" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-03062" ref-type="bibr">36</xref>]. Cells were bathed in high-K<sup>+</sup>, Ca<sup>2+</sup>-free solution, and the recording pipette was then filled with K<sup>+</sup>-enriched solution. <xref ref-type="fig" rid="molecules-25-03062-f005">Figure 5</xref> illustrates that the presence of SSM can result in a concentration-dependent depression in the amplitude of <italic>I</italic><sub>K(M)</sub> during step depolarization. The IC<sub>50</sub> value needed for an SSM-perturbed decrease of <italic>I</italic><sub>K(M)</sub> observed in GH<sub>3</sub> cells was 4.8 &#x003bc;M, a value noticeably higher than that used for its inhibitory effect on the late component of <italic>I</italic><sub>Na</sub> in response to brief depolarization.</p></sec><sec id="sec2dot7-molecules-25-03062"><title>2.7. Inhibitory Effect of SSM on Erg-Mediated K<sup>+</sup> Current (I<sub>K(erg)</sub>) in GH<sub>3</sub> Cells</title><p>We further explored whether SSM could perturb another types of K<sup>+</sup> currents (i.e., <italic>I</italic><sub>K(erg)</sub> and <italic>I</italic><sub>K(DR)</sub>) in these cells. As demonstrated previously [<xref rid="B15-molecules-25-03062" ref-type="bibr">15</xref>,<xref rid="B23-molecules-25-03062" ref-type="bibr">23</xref>,<xref rid="B37-molecules-25-03062" ref-type="bibr">37</xref>], to amplify the deactivated <italic>I</italic><sub>K(erg)</sub>, cells were bathed in high-K<sup>+</sup>, Ca<sup>2+</sup>-free solution. In this stage of the measurements, we bathed cells in high-K<sup>+</sup>, Ca<sup>2+</sup>-free solution containing 1 &#x003bc;M tetrodotoxin (TTX), and then filled up the electrodes by using K<sup>+</sup>-enriched solution. As depicted in <xref ref-type="fig" rid="molecules-25-03062-f006">Figure 6</xref>A,B, as cells were exposed to 30 &#x003bc;M SSM, the amplitude of <italic>I</italic><sub>K(erg)</sub> in response to negative potentials from &#x02212;10 mV was evidently decreased. <xref ref-type="fig" rid="molecules-25-03062-f006">Figure 6</xref>B represents the average <italic>I&#x02013;V</italic> relationship of deactivated <italic>I</italic><sub>K(erg)</sub> achieved in controls and during the exposure to 30 &#x003bc;M SSM. Therefore, SSM at a concentration higher than 30 &#x003bc;M can effectively depress the amplitude of <italic>I</italic><sub>K(erg)</sub> in GH<sub>3</sub> cells.</p></sec><sec id="sec2dot8-molecules-25-03062"><title>2.8. Mild Inhibitory Effect of SSM on Delayed Rectifier K<sup>+</sup> Currents (I<sub>K(DR)</sub>) in GH<sub>3</sub> Cells</title><p>We next examined whether the presence of SSM is able to modify <italic>I</italic><sub>K(DR)</sub> present in GH<sub>3</sub> cells. To achieve this goal, we bathed cells in Ca<sup>2+</sup>-free Tyrode&#x02019;s solution which contained 1 &#x003bc;M TTX, and then filled up the recording electrode by using K<sup>+</sup>-containing solution. When cells were exposed to SSM at a concentration of 3 &#x003bc;M, the amplitude of <italic>I</italic><sub>K(DR)</sub> in response to a 1-sec step depolarization was unchanged. It is noted, however, that the <italic>I</italic><sub>K(DR)</sub> amplitudes responding to different levels of depolarizing command steps were decreased by the addition of 10 &#x003bc;M SSM, though the activation time course of <italic>I</italic><sub>K(DR)</sub> evoked by membrane depolarization remained unchanged. For example, as the <italic>I</italic><sub>K(DR)</sub> amplitude was measured at the level of +40 mV, the presence of 10 &#x003bc;M SSM significantly decreased the current amplitude by 23 &#x000b1; 4% from 598 &#x000b1; 34 to 454 &#x000b1; 29 pA (n = 8, <italic>P</italic> &#x0003c; 0.05). The average <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>K(DR)</sub> obtained in the absence or presence of 10 &#x003bc;M was constructed and is hence illustrated in <xref ref-type="fig" rid="molecules-25-03062-f007">Figure 7</xref>.</p></sec><sec id="sec2dot9-molecules-25-03062"><title>2.9. Inability of SSM to Perturb Hyperpolarization-Activated Cation Currents (I<sub>h</sub>) in GH<sub>3</sub> Cells</title><p>In the following experiments, we further studied whether the presence of SSM could perturb another type of inwardly directed current, i.e., <italic>I</italic><sub>h</sub>. Cells were exposed to Ca<sup>2+</sup>-free Tyrode&#x02019;s solution containing 1 &#x003bc;M TTX and the pipette was filled with K<sup>+</sup>-containing solution. As the hyperpolarizing command pulse from &#x02212;40 to &#x02212;110 mV with a duration of 2 sec was delivered, <italic>I</italic><sub>h</sub> with a slowly activating property was robustly evoked, as observed previously [<xref rid="B16-molecules-25-03062" ref-type="bibr">16</xref>,<xref rid="B38-molecules-25-03062" ref-type="bibr">38</xref>,<xref rid="B39-molecules-25-03062" ref-type="bibr">39</xref>]. As illustrated in <xref ref-type="fig" rid="molecules-25-03062-f008">Figure 8</xref>, 1 min of exposure to SSM at a concentration of 10 &#x003bc;M was unable to modify the amplitude or gating (i.e., activation or deactivation kinetics) of <italic>I</italic><sub>h</sub> in response to a 2-sec hyperpolarizing pulse from &#x02212;40 to &#x02212;110 mV. For example, at the level of &#x02212;110 mV, the <italic>I</italic><sub>h</sub> amplitude measured at the end of the hyperpolarizing step between the absence and presence of 10 &#x003bc;M SSM did not differ (388 &#x000b1; 24 pA (control) versus 386 &#x000b1; 26 pA (in the presence of SSM); n = 9, <italic>P</italic> &#x0003e; 0.05). Similarly, the application of 10 &#x003bc;M SesA had a minimal effect on <italic>I</italic><sub>h</sub> amplitude. However, in the continued presence of SSM (10 &#x003bc;M), the subsequent application of cilobradine at a concentration of 3 or 10 &#x003bc;M was highly effective at inhibiting the <italic>I</italic><sub>h</sub> amplitude in combination with a measurable slowing in the activation time course of the current. Cilobradine has recently been reported to decrease <italic>I</italic><sub>h</sub> amplitude, as well as to alter activation kinetics present in different types of excitable cells [<xref rid="B39-molecules-25-03062" ref-type="bibr">39</xref>]. As such, distinguishable from its effect on <italic>I</italic><sub>Na</sub> or different types of K<sup>+</sup> currents demonstrated above, the addition of SSM failed to alter the amplitude and kinetics of <italic>I</italic><sub>h</sub> identified in GH<sub>3</sub> cells.</p></sec><sec id="sec2dot10-molecules-25-03062"><title>2.10. Simulations of SSM-Mediated Inhibition of I<sub>Na</sub> Derived From a Markov State Model</title><p>To further elucidate the ionic mechanism of the inhibitory actions of SSM, a modified Markovian model used to simulate <italic>I</italic><sub>Na</sub> (i.e., SCN8A-encoded (or Na<sub>V</sub>1.6) current) was examined. The mRNA transcripts for the &#x003b1;-subunit of Na<sub>V</sub>1.1, Na<sub>V</sub>1.2, Na<sub>V</sub>1.3, and Na<sub>V</sub>1.6 were reported to be present in GH<sub>3</sub> cells [<xref rid="B40-molecules-25-03062" ref-type="bibr">40</xref>,<xref rid="B41-molecules-25-03062" ref-type="bibr">41</xref>]. This model, illustrated in <xref ref-type="fig" rid="molecules-25-03062-f009">Figure 9</xref>A, was originally derived from Pan and Cummins [<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>]. The detailed meanings for the default parameters used in this model were previously elaborated [<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>]. Basically, the model consists of five closed states, one open state, one blocked state, and six inactivation states. As shown in <xref ref-type="fig" rid="molecules-25-03062-f009">Figure 9</xref>B, the inhibitory effect of SSM on simulated <italic>I</italic><sub>Na</sub> closely resembled the experimental observations reported above. The observations showed that the inhibitory effect of SSM at a concentration of 0.3 and 1 &#x003bc;M can be mimicked by an increase in Oon (i.e., transitional rate from the open to I6 state) to 3.5 and 4.6 msec<sup>&#x02212;1</sup> from a control value of 2.3 msec<sup>&#x02212;1</sup>. Therefore, a progression toward the activated state became considerably raised in the presence of 0.3 or 1 &#x003bc;M SSM by 25% or 50%, respectively. Overall, the simulation results produced a good match to the experimental observations which disclosed that, during cell exposure to SSM (0.3 or 1 &#x003bc;M), the current amplitude of simulated <italic>I</italic><sub>Na</sub> (i.e., <italic>SCN8A</italic>-encoded current) in response to a brief depolarization was decreased, along with a reduction in the inactivation time constant. Additionally, on the basis of our analysis, as demonstrated in <xref ref-type="fig" rid="molecules-25-03062-f009">Figure 9</xref>C, when the cells were exposed to SSM, the state probability in the OB state of the channel appeared to be sensitive to a decrease to a greater extent than that in the O state. For example, as the modeled cell was exposed to 1 &#x003bc;M SSM, the occupancy probability in the O state mildly decreased from 0.57 to 0.52, while that in the OB state resulted in a reduction from 0.079 to 0.046.</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-25-03062"><title>3. Discussion</title><p>The principal findings obtained in the present study are as follows. First, in pituitary GH<sub>3</sub> cells, SSM or SesA, known to be the therapeutic furofuran lignans of sesame oil [<xref rid="B1-molecules-25-03062" ref-type="bibr">1</xref>,<xref rid="B3-molecules-25-03062" ref-type="bibr">3</xref>,<xref rid="B14-molecules-25-03062" ref-type="bibr">14</xref>], differentially and effectively inhibited the transient and late components of <italic>I</italic><sub>Na</sub> in a concentration-dependent manner. Second, the addition of SSM can result in a modification of the inactivation kinetics of <italic>I</italic><sub>Na</sub> in response to brief depolarization. Third, the presence of SSM could inhibit the amplitude of <italic>I</italic><sub>Na(R)</sub>. Fourth, its presence concentration-dependently depressed the amplitude of <italic>I</italic><sub>K(M)</sub>. Fifth, the presence of SSM mildly decreased the amplitude of <italic>I</italic><sub>K(erg)</sub> and <italic>I</italic><sub>K(M)</sub>. Sixth, SSM itself was unable to alter the amplitude or gating of hyperpolarization-elicited <italic>I</italic><sub>h</sub>. Seventh, according to a Markovian model designed from the SCN8A channel adopted previously [<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>], SSM-perturbed changes in the gating kinetics of Na<sub>V</sub> channels could be predictably described from their lowering of the probability of open (O) and open-blocked (OB) states of the channel. Overall, the experimental and simulation results found here meant that the inhibition by SSM of these ion channels can be caused by one of several ionic mechanisms underlying its remarkable changes to the functional activities of different types of electrically excitable cells, supposing that similar observations can be found in vivo. To what extent these compounds have therapeutic relevance in the treatment of patients with epilepsy remains to be studied.</p><p>A noticeable feature of the block of <italic>I</italic><sub>Na</sub> caused by SSM in GH<sub>3</sub> cells is that the initial rising phase of the current (i.e., activation time course) was unaffected. However, the inhibitory effects of SSM on <italic>I</italic><sub>Na</sub> are not restricted to its suppression of the peak component of the current. As was expected, increasing the SSM concentration not only decreased the peak component of <italic>I</italic><sub>Na</sub> responding to rapid membrane depolarization, but also accelerated the inactivation rate of the current. The SSM molecule appeared in the blocking only when the Na<sub>V</sub> channel was in the open state. This feature can be incorporated into a simple kinetic scheme (i.e., <inline-formula><mml:math id="mm4"><mml:mrow><mml:mrow><mml:mi>closed</mml:mi><mml:mo>&#x02194;</mml:mo><mml:mi>open</mml:mi><mml:mo>&#x02194;</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> open-blocked), as demonstrated in <xref ref-type="fig" rid="molecules-25-03062-f001">Figure 1</xref>C. As such, it is most likely that SSM or SesA preferentially binds to and blocks the open state of the Na<sub>V</sub> channels.</p><p>In this study, we observed that SSM at the concentrations falling in the range between 0.1 and 0.3 &#x003bc;M caused little or no effect on the peak component of <italic>I</italic><sub>Na</sub> in response to brief membrane depolarization, whereas, at the same concentration, it effectively blocked the sustained component of <italic>I</italic><sub>Na</sub>. In this scenario, the calculated IC<sub>50</sub> value of SSM, which was required for the inhibition of sustained <italic>I</italic><sub>Na</sub>, tends to be lower than that for its inhibitory effect on peak <italic>I</italic><sub>Na</sub>, highly reflecting that there is a considerable and selective block of sustained <italic>I</italic><sub>Na</sub> caused by SSM. Meanwhile, the exposure to SSM produced a reduction in the amplitude of <italic>I</italic><sub>Na(R)</sub>, though no change in the overall <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>Na(R)</sub> was obtained in its presence.</p><p>Sesame oil was shown to exert protective effects against cypermethrin-induced damage in genomic DNA and histopathological changes in the brain or hematotoxicities [<xref rid="B13-molecules-25-03062" ref-type="bibr">13</xref>,<xref rid="B43-molecules-25-03062" ref-type="bibr">43</xref>]. It was reported to prevent the deleterious effect of cypermethrin in rat liver and kidney [<xref rid="B44-molecules-25-03062" ref-type="bibr">44</xref>,<xref rid="B45-molecules-25-03062" ref-type="bibr">45</xref>]. The present observations showed that the SSM-mediated inhibition of <italic>I</italic><sub>Na</sub> could be counteracted by a further application of tefluthrin, structurally similar to cypermethrin, suggesting that pyrethroid-induced neurotoxicity could be reversed by SSM or SesA.</p><p>It should be noticed that the neurological or cardioprotective actions caused by SSM, SesA, or other structurally similar compounds, as described previously [<xref rid="B42-molecules-25-03062" ref-type="bibr">42</xref>,<xref rid="B46-molecules-25-03062" ref-type="bibr">46</xref>,<xref rid="B47-molecules-25-03062" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-03062" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-03062" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-03062" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-03062" ref-type="bibr">51</xref>,<xref rid="B52-molecules-25-03062" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-03062" ref-type="bibr">53</xref>], can be intimately linked to their direct actions on the amplitude and gating of ion currents (e.g., <italic>I</italic><sub>Na</sub>). Similar to the ranolazine or perampanel action on <italic>I</italic><sub>Na</sub> described previously [<xref rid="B23-molecules-25-03062" ref-type="bibr">23</xref>,<xref rid="B25-molecules-25-03062" ref-type="bibr">25</xref>], the inhibitory effect of SSM on ion currents seen herein may be responsible for its wide spectrum of effects observed in vivo [<xref rid="B3-molecules-25-03062" ref-type="bibr">3</xref>,<xref rid="B54-molecules-25-03062" ref-type="bibr">54</xref>]. Additionally, caution needs to be taken in the interpretation of sesame oil as a fat-soluble vehicle [<xref rid="B55-molecules-25-03062" ref-type="bibr">55</xref>,<xref rid="B56-molecules-25-03062" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-03062" ref-type="bibr">57</xref>].</p><p>The present observations also revealed that SSM could decrease the amplitude of <italic>I</italic><sub>K(M)</sub> in GH<sub>3</sub> cells with an IC<sub>50</sub> of 4.8 &#x003bc;M. <italic>I</italic><sub>K(M)</sub> is biophysically characterized by a slow activation and deactivation property during step depolarization [<xref rid="B34-molecules-25-03062" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-03062" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-03062" ref-type="bibr">36</xref>]. It needs to be noticed, therefore, that the inhibition of <italic>I</italic><sub>Na</sub> caused by SSM or SesA could be indirectly and concurrently altered by their inhibitory effects on <italic>I</italic><sub>K(M)</sub> observed in non-voltage-clamped cells, since the suppression of <italic>I</italic><sub>Na</sub> amplitude would be further exacerbated by the membrane depolarization produced by <italic>I</italic><sub>K(M)</sub> inhibition. In other words, the SSM-mediated inhibition of <italic>I</italic><sub>Na</sub> and <italic>I</italic><sub>K(M)</sub> studied herein likely synergistically influences the functional activities of electrically excitable cells such as pituitary lactotrophs. However, whether different lignans in dietary vegetables produce similar actions to the ones observed here still remains to be further examined.</p><p>The voltage-clamp current measurements are unable to realize the changes of the occupancy probability of each state simultaneously. In this study, the biophysical model (<xref ref-type="fig" rid="molecules-25-03062-f009">Figure 9</xref>A) adopted in the present study [<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>] tends to be based on a relatively small number of variables. However, it allowed us to virtually highlight a qualitative way of how the presence of SSM perturbs the amplitude and gating of <italic>I</italic><sub>Na</sub>. As such, the model demonstrated herein is able to complement the experimental observations by providing insight into the gating of Na<sub>V</sub> channels, which can impinge upon the electrical behavior of neurons or neuroendocrine cells. Our simulation results generated from this model support the notion that changes in the magnitude and kinetics of <italic>I</italic><sub>Na</sub> caused by SSM, in which varying value of Oon is the valuable parameter involved, are responsible for its actions on the functional activity of electrically excitable cells in vivo, though other additional variables also likely take part in the regulation of <italic>I</italic><sub>Na</sub> kinetics. Oon, appearing in the model, is the on rate of normal inactivation from the open state of the Na<sub>V</sub> channel. Overall, the findings from the present simulations disclose that the decreases in both peak amplitude and the inactivation time constant of <italic>I</italic><sub>Na</sub>, in which the SSM action is mimicked, could be a potentially important mechanism underlying the rate and pattern of repetitive firing in electrically excitable cells appearing in vivo.</p></sec><sec id="sec4-molecules-25-03062"><title>4. Materials and Methods </title><sec id="sec4dot1-molecules-25-03062"><title>4.1. Chemicals and Solutions</title><p>This study used (+)-Sesamin (SSM; C<sub>20</sub>H<sub>18</sub>O<sub>6</sub>, [1S-(1&#x003b1;,3a&#x003b1;,4&#x003b1;,6a&#x003b1;)] -5,5&#x02019;- (tetrahydro-1H,3H-furo [3&#x02013;4-c]furan-1,4-diyl)<italic>bis</italic>-1,3-benzodioxole, <uri xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/sesamin">https://pubchem.ncbi.nlm.nih.gov/compound/sesamin</uri>) and (+)-sesamolin (SesA; C<sub>20</sub>H<sub>18</sub>O<sub>7</sub>, 5-[(1S,3aR,4R,6aR)-4-(1,3-benzodioxol-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole, <uri xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/585998">https://pubchem.ncbi.nlm.nih.gov/compound/585998</uri>). The methanol extract of sesame (<italic>Sesamum indicum</italic>) seeds was fractionated and purified with the assistance of conventional column chromatography to afford 29 compounds, including seven furofuran lignans. Both the extraction or fractionation of medicinal plants (i.e., sesame oil) and the basic chemical structure of SSM or SesM are illustrated in a previous paper [<xref rid="B5-molecules-25-03062" ref-type="bibr">5</xref>]. The purity of (+)-sesamin and (+)-sesamolin, as well as the specific rotation ([a]<sub>D</sub> value), are shown in the <xref ref-type="app" rid="app1-molecules-25-03062">Supplementary Information</xref>.</p><p>Cilobradine (CIL) was obtained from Cayman (Excel Biomedical, Taipei, Taiwan), tefluthrin (Tef), tetraethylammonium chloride (TEA), and tetrodotoxin (TTX) were from Sigma-Aldrich (Merck Ltd., Taipei, Taiwan) and telmisartan (Tel) was from Tocris (Union Biomed Inc., Taipei, Taiwan). Unless otherwise stated, culture media (e.g., Ham&#x02019;s F-12 medium), fetal bovine serum, horse serum, L-glutamine, and trypsin/EDTA were acquired from HyClone<sup>TM</sup> (Thermo Fisher; Level Biotech, Tainan, Taiwan), while other chemicals and reagents were of analytical grade.</p><p>The bath solution (i.e., a HEPES-buffered normal Tyrode&#x02019;s solution) utilized in the present study was composed of 136 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl<sub>2</sub>, 0.53 mM MgCl<sub>2</sub>, 5.5 mM glucose, and 5.5 mM HEPES titrated with NaOH to pH 7.4. To measure macroscopic <italic>I</italic><sub>K(DR)</sub> and <italic>I</italic><sub>h</sub>, we filled patch pipettes by using a solution containing 130 mM K-aspartate, 20 mM KCl, 1 mM KH<sub>2</sub>PO<sub>4</sub>, 1 mM MgCl<sub>2</sub>, 3 mM Na<sub>2</sub>ATP, 0.1 mM Na<sub>2</sub>GTP, 0.1 mM EGTA, and 5 mM HEPES adjusted with KOH to pH 7.2. To record <italic>I</italic><sub>Na</sub> and <italic>I</italic><sub>Na(R)</sub>, we substituted K<sup>+</sup> ions in the pipette solution inside the electrode for equmolar Cs<sup>+</sup> ions and the pH value in the solution was adjusted to 7.2 with CsOH. To measure <italic>I</italic><sub>K(erg)</sub> and <italic>I</italic><sub>K(M)</sub>, cells were bathed in a high-K<sup>+</sup> solution containing 145 mM KCl, 0.53 mM MgCl<sub>2</sub>, and 5 mM HEPES-KOH buffer, pH 7.4. All solutions were prepared using deionized water from a Millipore Milli-Q purification system (&#x003c1; = 18 M&#x003a9;&#x000b7;cm) (Merck, Ltd., Taipei, Taiwan). The pipette solution and culture medium were filtered on the day of use with a sterile Acrodisc<sup>&#x000ae;</sup> syringe filter with a 0.2-&#x003bc;m Supor<sup>&#x000ae;</sup> membrane (Bio-Check; New Taipei City, Taiwan).</p></sec><sec id="sec4dot2-molecules-25-03062"><title>4.2. Cell Culture</title><p>The pituitary adenomatous cell line, GH<sub>3</sub>, was acquired from the Bioresource Collection and Research Center ((BCRC-60015, <uri xlink:href="https://catalog.bcrc.firdi.org.tw/BcrcContent?bid=60015">https://catalog.bcrc.firdi.org.tw/BcrcContent?bid=60015</uri>); Hsinchu, Taiwan). Cells were maintained in Ham&#x02019;s F-12 medium supplemented with 2.5% fetal bovine serum (v/v), 15% horse serum (v/v), and 2 mM L-glutamine in a humidified environment of 5% CO<sub>2</sub>/95% air [<xref rid="B31-molecules-25-03062" ref-type="bibr">31</xref>,<xref rid="B38-molecules-25-03062" ref-type="bibr">38</xref>]. When well differentiated, GH<sub>3</sub> cells were transferred to a serum- and Ca<sup>2+</sup>-free medium. Electrical recordings were performed 5 or 6 days after cells were cultured with 60&#x02013;80% confluence.</p></sec><sec id="sec4dot3-molecules-25-03062"><title>4.3. Electrophysiological Measurements</title><p>On the day of each experiment, cells were dispersed with a 1% trypsin/EDTA solution and a few drops of cell suspension were rapidly placed in a custom-built recording chamber mounted on the stage of an inverted DM-IL microscope (Leica; Major Instruments, Kaohsiung, Taiwan). They were immersed at room temperature (20&#x02013;25 &#x000b0;C) in normal Tyrode&#x02019;s solution, the composition of which is elaborated above. We measured ion currents in the whole-cell model of a standard patch-clamp technique with dynamic adaptive suctioning (i.e., decremental change of suction pressure in response to a progressive increase in the electrode resistance), with the aid of an RK-400 (Bio-Logic, Claix, France) or an Axopatch-200B (Molecular Devices, Sunnyvale, CA) patch amplifier [<xref rid="B33-molecules-25-03062" ref-type="bibr">33</xref>,<xref rid="B38-molecules-25-03062" ref-type="bibr">38</xref>,<xref rid="B58-molecules-25-03062" ref-type="bibr">58</xref>]. The microelectrodes used were prepared from Kimax-51 borosilicate capillaries with a 1.5-mm outer diameter (#34500; Kimble; Dogger, New Taipei City, Taiwan) by using a PP-830 vertical puller (Narishige, Taiwan Instrument, Taipei, Taiwan). The recording electrodes had their tip resistances, which ranged between 3 and 5 M&#x003a9;, as they were filled up with the different internal solutions elaborated above. During the measurements, the recorded area on the vibration-free table was shielded by using a Faraday cage (Scitech, Seoul, South Korea). The potentials were corrected for the liquid&#x02013;liquid junction potential that would appear when the composition of the pipette solution remained different from that in the bath.</p></sec><sec id="sec4dot4-molecules-25-03062"><title>4.4. Data Recordings</title><p>The signals, composed of potential and current traces, were monitored on an HM-507 oscilloscope (Hameg, East Meadow, NY) and digitally stored online at 10 kHz in a Sony VAIO CS series laptop computer (VGN-CS110E; Kaohsiung, Taiwan) equipped with a 12-bit resolution Digidata 1440A interface (Molecular Devices). During the recordings with either analog-to-digital or digital-to-analog conversion, the latter device was controlled by pCLAMP 10.7 software (Molecular Devices) run on Microsoft Windows 10 (Redmond, WA). The laptop computer used was also put on the top of an adjustable Cookskin stand (Ningbo, Zheijiang, China) for efficient manipulation during the experiments.</p></sec><sec id="sec4dot5-molecules-25-03062"><title>4.5. Data Analyses</title><p>The digitized signals were examined and analyzed offline using different programs, such as pCLAMP 10.7 (Molecular Devices), 64-big OriginPro 2016 (OriginLab, Taipei, Taiwan), Prism 6 (GraphPad; SoftHome International, Taipei, Taiwan), or custom-made macros created in Microsoft Excel<sup>&#x000ae;</sup> 2013, which was executed on Windows 10 (Redmond, WA). The concentration&#x02013;response data for the inhibition of either peak and late <italic>I</italic><sub>Na</sub> and <italic>I</italic><sub>K(M)</sub> inherently in GH<sub>3</sub> cells were least-squares fitted to the modified Hill equation, which can be written as follows:<disp-formula id="FD3-molecules-25-03062"><label>(3)</label><mml:math id="mm5"><mml:mrow><mml:mrow><mml:mrow><mml:mi>percentage</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>inhibition</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>&#x000d7;</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>C</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>H</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>C</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>H</mml:mi></mml:msub></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>H</mml:mi></mml:msub></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>
where [C] denotes the SSM or SesA concentration given; IC<sub>50</sub> and n<sub>H</sub> represent the concentration required for a 50% inhibition and the Hill coefficient, respectively; and <italic>E</italic><sub>max</sub> is the maximal inhibition of either peak and late <italic>I</italic><sub>Na</sub> or <italic>I</italic><sub>K(M)</sub> caused by the different concentrations of SSM or SesA.</p></sec><sec id="sec4dot6-molecules-25-03062"><title>4.6. Statistical Analyses</title><p>Linearized or non-linearized curve fitting to the data sets was performed using either pCLAMP 10.7 (Molecule Devices), OriginPro (OriginLab), or Prism 6.0 (GraphPad). All data are presented as mean value &#x000b1; SEM with sample sizes (n) indicative of the cell numbers from which the data were collected; error bars are plotted as SEM. Paired or unpaired Student&#x02019;s <italic>t</italic>-tests were initially applied for the statistical analyses. As the statistical difference among different groups was necessarily determined, we performed either analysis of variance (ANOVA)-1 or ANOVA-2 with or without repeated measures followed by Duncan&#x02019;s post hoc test. A <italic>P</italic>-value of &#x0003c; 0.05 was considered to indicate statistical difference.</p></sec><sec id="sec4dot7-molecules-25-03062"><title>4.7. Computer Simulations</title><p>To simulate both the increase in the degree of the <italic>I</italic><sub>Na</sub> inactivation rate and the decrease in the peak <italic>I</italic><sub>Na</sub>, a modified Pan&#x02013;Cummins model was mathematically constructed in the study. The state model of the <italic>SCN8A</italic>-encoded (or Na<sub>V</sub>1.6) channel which we employed in this work has been described in previous studies [<xref rid="B21-molecules-25-03062" ref-type="bibr">21</xref>,<xref rid="B59-molecules-25-03062" ref-type="bibr">59</xref>,<xref rid="B60-molecules-25-03062" ref-type="bibr">60</xref>]. Such a kinetic scheme that can take into account the obtained results is described below, where C is the final closed state before opening, O is an open state, I is an inactivated state, and OB is a blocked state. The simple <xref ref-type="scheme" rid="molecules-25-03062-sch001">Scheme 1</xref> is given as follows:</p><p>The programs designed in the present study were written in the XPP simulation package available in <uri xlink:href="http://www.math.pitt.edu/~bard/xpp/xpp.html">http://www.math.pitt.edu/~bard/xpp/xpp.html</uri>. Differential equations were solved by a fourth order Runge&#x02013;Kutta algorithm. Parts of the numerical simulations were also verified with Microsoft Excel [<xref rid="B20-molecules-25-03062" ref-type="bibr">20</xref>,<xref rid="B61-molecules-25-03062" ref-type="bibr">61</xref>].</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to acknowledge Kaisen Lee for technical assistance in the earlier work.</p></ack><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds are available from the authors.</p></fn></fn-group><app-group><app id="app1-molecules-25-03062"><title>Supplementary Materials</title><p>The following are available online. The purity of (+)-sesamin and (+)-sesamolin, as well as the specific rotation ([a]<sub>D</sub> value), are shown in the Supplementary Information.</p><supplementary-material content-type="local-data" id="molecules-25-03062-s001"><media xlink:href="molecules-25-03062-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, P.-C.K. and S.-N.W.; methodology, Z.-H.K., S.-W.L., and S.-N.W.; software, Z.-H.K. and S.-W.L.; validation, P.-C.K. and S.-N.W.; formal analysis, Z.-H.K., S.-W.L.; resources, P.-C.K. and S.-N.W.; data curation, Z.-H.K. and S.-W.L.; writing&#x02014;original draft preparation, P.-C.K.; writing&#x02014;review and editing, S.-N.W.; supervision, S.-N.W.; funding acquisition, P.-C.K. and S.-N.W. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work detailed herein was financially supported by a grant from the Ministry of Sciences and Technology (MOST-108-2314-B-006-094), Taiwan.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest, financial or otherwise. The authors alone are responsible for the content and writing of the paper.</p></notes><glossary><title>Abbreviations</title><p>CIL: cilobradine; <italic>I&#x02013;V</italic>, current versus voltage; IC<sub>50</sub>, the concentration required for 50% inhibition; <italic>I</italic><sub>h</sub>, hyperpolarization-activated cation current; <italic>I</italic><sub>K(DR)</sub>, delayed rectifier K<sup>+</sup> current; <italic>I</italic><sub>K(erg)</sub>, <italic>erg</italic>-mediated K<sup>+</sup> current; <italic>I</italic><sub>K(M)</sub>, M-type K<sup>+</sup> current; <italic>I</italic><sub>Na</sub>, voltage-gated Na<sup>+</sup> current; <italic>I</italic><sub>Na(R)</sub>, resurgent <italic>I</italic><sub>Na</sub>; Na<sub>V</sub> channel, voltage-gated Na<sup>+</sup> channel; <italic>K</italic><sub>D</sub>, dissociation constant; SEM, standard error of mean; SSM, sesamin; SesA, sesamolin; &#x003c4;<sub>inact(S)</sub>, slow component in the inactivation time constant of <italic>I</italic><sub>Na</sub>; TEA, tetraethylammonium chloride; Tef, tefluthrin; Tel telmisartan; TTX, tetrodotoxin.</p></glossary><ref-list><title>References</title><ref id="B1-molecules-25-03062"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraj</surname><given-names>P.</given-names></name><name><surname>Narasimhulu</surname><given-names>C.A.</given-names></name><name><surname>Rajagopalan</surname><given-names>S.</given-names></name><name><surname>Parthasarathy</surname><given-names>S.</given-names></name><name><surname>Desikan</surname><given-names>R.</given-names></name></person-group><article-title>Sesamol: A powerful functional food ingredient from sesame oil for cardioprotection</article-title><source>Food Funct.</source><year>2020</year><volume>11</volume><fpage>1198</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1039/C9FO01873E</pub-id><pub-id pub-id-type="pmid">32037412</pub-id></element-citation></ref><ref id="B2-molecules-25-03062"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>E.Y.</given-names></name><name><surname>Rodriguez</surname><given-names>I.</given-names></name><name><surname>Nam</surname><given-names>Y.H.</given-names></name><name><surname>Jeong</surname><given-names>S.Y.</given-names></name><name><surname>Hong</surname><given-names>B.N.</given-names></name><name><surname>Choung</surname><given-names>S.Y.</given-names></name><name><surname>Kang</surname><given-names>T.H.</given-names></name></person-group><article-title><italic>Sesamum indicum</italic> L. and sesamin induce auditory-protective effects through changes in hearing loss-related gene expression</article-title><source>J. Med. Food</source><year>2020</year><volume>23</volume><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1089/jmf.2019.4542</pub-id><pub-id pub-id-type="pmid">32186941</pub-id></element-citation></ref><ref id="B3-molecules-25-03062"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>K.C.G.</given-names></name><name><surname>Hou</surname><given-names>R.C.W.</given-names></name></person-group><article-title>Sesamin and sesamolin: Nature&#x02019;s therapeutic lignans</article-title><source>Curr. Enzym. Inhib.</source><year>2005</year><volume>1</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.2174/1573408052952748</pub-id></element-citation></ref><ref id="B4-molecules-25-03062"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T.</given-names></name><name><surname>Shingai</surname><given-names>Y.</given-names></name><name><surname>Fujimoto</surname><given-names>A.</given-names></name><name><surname>Nakamura</surname><given-names>M.</given-names></name><name><surname>Oyama</surname><given-names>Y.</given-names></name><name><surname>Maekawa</surname><given-names>T.</given-names></name><name><surname>Sone</surname><given-names>Y.</given-names></name></person-group><article-title>Identification of cytotoxic dimers in oxidation product from sesamol, a potent antioxidant of sesame oil</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>10880</fpage><lpage>10885</lpage><pub-id pub-id-type="doi">10.1021/jf103015j</pub-id><pub-id pub-id-type="pmid">20925385</pub-id></element-citation></ref><ref id="B5-molecules-25-03062"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P.C.</given-names></name><name><surname>Lin</surname><given-names>M.C.</given-names></name><name><surname>Chen</surname><given-names>G.F.</given-names></name><name><surname>Yiu</surname><given-names>T.J.</given-names></name><name><surname>Tzen</surname><given-names>J.T.C.</given-names></name></person-group><article-title>Identification of methanol-soluble compounds in sesame and evaluation of antioxidant potentials of its lignans</article-title><source>J. Agric. Food Chem.</source><year>2011</year><volume>59</volume><fpage>3214</fpage><lpage>3219</lpage><pub-id pub-id-type="doi">10.1021/jf104311g</pub-id><pub-id pub-id-type="pmid">21391595</pub-id></element-citation></ref><ref id="B6-molecules-25-03062"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baluchnejadmojarad</surname><given-names>T.</given-names></name><name><surname>Mansouri</surname><given-names>M.</given-names></name><name><surname>Ghalami</surname><given-names>J.</given-names></name><name><surname>Mokhtari</surname><given-names>Z.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name></person-group><article-title>Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>88</volume><fpage>754</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.01.123</pub-id><pub-id pub-id-type="pmid">28157651</pub-id></element-citation></ref><ref id="B7-molecules-25-03062"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A.Y.</given-names></name><name><surname>Yun</surname><given-names>C.I.</given-names></name><name><surname>Lee</surname><given-names>J.G.</given-names></name><name><surname>Kim</surname><given-names>Y.J.</given-names></name></person-group><article-title>Determination and daily intake estimation of lignans in sesame seeds and sesame oil products in Korea</article-title><source>Foods</source><year>2020</year><volume>9</volume><elocation-id>394</elocation-id><pub-id pub-id-type="doi">10.3390/foods9040394</pub-id></element-citation></ref><ref id="B8-molecules-25-03062"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhar</surname><given-names>P.</given-names></name><name><surname>Chattopadhya</surname><given-names>K.</given-names></name><name><surname>Bhattacharyya</surname><given-names>D.</given-names></name><name><surname>Biswas</surname><given-names>A.</given-names></name><name><surname>Roy</surname><given-names>B.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Ameliorative influence of sesame lignans on lipid profile and lipid peroxidation in induced diabetic rats</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>5875</fpage><lpage>5880</lpage><pub-id pub-id-type="doi">10.1021/jf063721b</pub-id><pub-id pub-id-type="pmid">17571897</pub-id></element-citation></ref><ref id="B9-molecules-25-03062"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.T.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Jiao</surname><given-names>R.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name><name><surname>Lei</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>K.Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cholesterol-lowering activity of sesamin is associated with down-regulation on genes of sterol transporters involved in cholesterol absorption</article-title><source>J. Agric. Food Chem.</source><year>2015</year><volume>63</volume><fpage>2963</fpage><lpage>2969</lpage><pub-id pub-id-type="doi">10.1021/jf5063606</pub-id><pub-id pub-id-type="pmid">25745846</pub-id></element-citation></ref><ref id="B10-molecules-25-03062"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>S.</given-names></name><name><surname>Akimoto</surname><given-names>K.</given-names></name><name><surname>Shinmen</surname><given-names>Y.</given-names></name><name><surname>Kawashima</surname><given-names>H.</given-names></name><name><surname>Sugano</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>H.</given-names></name></person-group><article-title>Sesamin is a potent and specific inhibitor of &#x00394;<sup>5</sup> desaturase in polyunsaturated fatty acid biosynthesis</article-title><source>Lipids</source><year>1991</year><volume>26</volume><fpage>512</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1007/BF02536595</pub-id><pub-id pub-id-type="pmid">1943494</pub-id></element-citation></ref><ref id="B11-molecules-25-03062"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>R.C.W.</given-names></name><name><surname>Huang</surname><given-names>H.M.</given-names></name><name><surname>Tzen</surname><given-names>J.T.C.</given-names></name><name><surname>Jeng</surname><given-names>K.C.G.</given-names></name></person-group><article-title>Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells</article-title><source>J. Neurosci. Res.</source><year>2003</year><volume>74</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1002/jnr.10749</pub-id><pub-id pub-id-type="pmid">13130514</pub-id></element-citation></ref><ref id="B12-molecules-25-03062"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamarkattel-Pandit</surname><given-names>N.</given-names></name><name><surname>Pandit</surname><given-names>N.R.</given-names></name><name><surname>Kim</surname><given-names>M.Y.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Bu</surname><given-names>Y.</given-names></name></person-group><article-title>Neuroprotective effect of defatted sesame seeds extract against in vitro and in vivo ischemic neuronal damage</article-title><source>Planta Med.</source><year>2010</year><volume>76</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1185903</pub-id><pub-id pub-id-type="pmid">19598078</pub-id></element-citation></ref><ref id="B13-molecules-25-03062"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruankham</surname><given-names>W.</given-names></name><name><surname>Suwanjang</surname><given-names>W.</given-names></name><name><surname>Wongchitrat</surname><given-names>P.</given-names></name><name><surname>Prachayasittikul</surname><given-names>V.</given-names></name><name><surname>Prachayasittikul</surname><given-names>S.</given-names></name><name><surname>Phopin</surname><given-names>K.</given-names></name></person-group><article-title>Sesamin and sesamol attenuate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress on human neuronal cells via the SIRT1-SIRT3-FOXO3a signaling pathway</article-title><source>Nutr. Neurosci.</source><comment>in press</comment><pub-id pub-id-type="doi">10.1080/1028415X.2019.1596613</pub-id><pub-id pub-id-type="pmid">30929586</pub-id></element-citation></ref><ref id="B14-molecules-25-03062"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>D.</given-names></name><name><surname>Itoh</surname><given-names>C.</given-names></name><name><surname>Takaoka</surname><given-names>M.</given-names></name><name><surname>Kiso</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Matsumura</surname><given-names>Y.</given-names></name></person-group><article-title>Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin</article-title><source>Biol. Pharm. Bull.</source><year>2002</year><volume>25</volume><fpage>1247</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1248/bpb.25.1247</pub-id><pub-id pub-id-type="pmid">12230131</pub-id></element-citation></ref><ref id="B15-molecules-25-03062"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>H.T.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>On the mechanism of selective action of probucol on the inwardly rectifying potassium current in GH<sub>3</sub> lactotrophs</article-title><source>Drug Dev. Res.</source><year>2001</year><volume>54</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1002/ddr.1198</pub-id></element-citation></ref><ref id="B16-molecules-25-03062"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Gao</surname><given-names>Z.H.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Evidence for effective inhibitory actions on hyperpolarization-activated cation current caused by <italic>Ganoderma</italic> triterpenoids, the main active constituents of <italic>Ganoderma</italic> spores</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>4256</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24234256</pub-id></element-citation></ref><ref id="B17-molecules-25-03062"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group><article-title>Channel, neuronal and clinical function in sodium channelopathies: From genotype to phenotype</article-title><source>Nat. Neurosci.</source><year>2007</year><volume>10</volume><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1038/nn1857</pub-id><pub-id pub-id-type="pmid">17387329</pub-id></element-citation></ref><ref id="B18-molecules-25-03062"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerche</surname><given-names>H.</given-names></name><name><surname>Shah</surname><given-names>M.</given-names></name><name><surname>Beck</surname><given-names>H.</given-names></name><name><surname>Noebels</surname><given-names>J.</given-names></name><name><surname>Johnston</surname><given-names>D.</given-names></name><name><surname>Vincent</surname><given-names>A.</given-names></name></person-group><article-title>Ion channels in genetic and acquired forms of epilepsy</article-title><source>J. Physiol.</source><year>2013</year><volume>591</volume><fpage>753</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2012.240606</pub-id><pub-id pub-id-type="pmid">23090947</pub-id></element-citation></ref><ref id="B19-molecules-25-03062"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waszkielewicz</surname><given-names>A.M.</given-names></name><name><surname>Gunia</surname><given-names>A.</given-names></name><name><surname>Szkaradek</surname><given-names>N.</given-names></name><name><surname>Sloczy&#x00144;ska</surname><given-names>K.</given-names></name><name><surname>Krupi&#x00144;ska</surname><given-names>S.</given-names></name><name><surname>Marona</surname><given-names>H.</given-names></name></person-group><article-title>Ion channels as drug targets in central nervous system disorders</article-title><source>Curr. Med. Chem.</source><year>2013</year><volume>20</volume><fpage>1241</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.2174/0929867311320100005</pub-id><pub-id pub-id-type="pmid">23409712</pub-id></element-citation></ref><ref id="B20-molecules-25-03062"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>T.T.</given-names></name><name><surname>Yang</surname><given-names>C.J.</given-names></name><name><surname>Lee</surname><given-names>Y.C.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Stimulatory action of telmisartan, an antagonist of angiotensin II receptor, on voltage-gated Na<sup>+</sup> current: Experimental and theoretical studies</article-title><source>Chin. J. Physiol.</source><year>2018</year><volume>61</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.4077/CJP.2018.BAG516</pub-id><pub-id pub-id-type="pmid">29374954</pub-id></element-citation></ref><ref id="B21-molecules-25-03062"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Cummins</surname><given-names>T.R.</given-names></name></person-group><article-title>Distinct functional alterations in <italic>SCN8A</italic> epilepsy mutant channels</article-title><source>J. Physiol.</source><year>2020</year><volume>598</volume><fpage>381</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1113/JP278952</pub-id><pub-id pub-id-type="pmid">31715021</pub-id></element-citation></ref><ref id="B22-molecules-25-03062"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>W.A.</given-names></name><name><surname>Goldin</surname><given-names>A.L.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group><article-title>International Union of Pharmacology, XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels</article-title><source>Pharmacol. Res.</source><year>2005</year><volume>57</volume><fpage>397</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1124/pr.57.4.4</pub-id><pub-id pub-id-type="pmid">16382098</pub-id></element-citation></ref><ref id="B23-molecules-25-03062"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.S.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Hsu</surname><given-names>T.I.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Effects of ranolazine, a novel anti-anginal drug, on ion currents and membrane potential in pituitary tumor GH<sub>3</sub> cells and NG108-15 neuronal cells</article-title><source>J. Pharmacol. Sci.</source><year>2009</year><volume>110</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1254/jphs.09018FP</pub-id><pub-id pub-id-type="pmid">19609066</pub-id></element-citation></ref><ref id="B24-molecules-25-03062"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.W.</given-names></name><name><surname>Chow</surname><given-names>J.C.</given-names></name><name><surname>Tsai</surname><given-names>J.J.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Characterizing the effects of eugenol on neuronal ionic currents and hyperexcitability</article-title><source>Psychopharmacol. Berl.</source><year>2012</year><volume>221</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1007/s00213-011-2603-y</pub-id><pub-id pub-id-type="pmid">22160139</pub-id></element-citation></ref><ref id="B25-molecules-25-03062"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>M.C.</given-names></name><name><surname>Tzeng</surname><given-names>R.C.</given-names></name><name><surname>Huang</surname><given-names>C.W.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>The novel direct modulatory effects of perampanel, an antagonist of AMPA receptors, on voltage-gated sodium and M-type potassium currents</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>638</elocation-id><pub-id pub-id-type="doi">10.3390/biom9100638</pub-id><pub-id pub-id-type="pmid">31652643</pub-id></element-citation></ref><ref id="B26-molecules-25-03062"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>T.H.</given-names></name><name><surname>Jin</surname><given-names>S.W.</given-names></name><name><surname>Lee</surname><given-names>G.H.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Thai</surname><given-names>T.N.</given-names></name><name><surname>Han</surname><given-names>E.H.</given-names></name><name><surname>Jeong</surname><given-names>H.G.</given-names></name></person-group><article-title>Sesamin induces endothelial nitric oxide synthase activation via transient receptor potential vanilloid type 1</article-title><source>J. Agric. Food Chem.</source><year>2020</year><volume>68</volume><fpage>3474</fpage><lpage>3484</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.9b07909</pub-id><pub-id pub-id-type="pmid">32077699</pub-id></element-citation></ref><ref id="B27-molecules-25-03062"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Effects of sesamin on streptozotocin (STZ)-induced NIT-1 pancreatic &#x003b2;-cell damage</article-title><source>Int. J. Mol. Sci.</source><year>2012</year><volume>13</volume><fpage>16961</fpage><lpage>16970</lpage><pub-id pub-id-type="doi">10.3390/ijms131216961</pub-id><pub-id pub-id-type="pmid">23443130</pub-id></element-citation></ref><ref id="B28-molecules-25-03062"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>G.D.</given-names></name><name><surname>Ma</surname><given-names>M.Z.</given-names></name><name><surname>Deng</surname><given-names>R.Y.</given-names></name><name><surname>Guo</surname><given-names>L.Q.</given-names></name><name><surname>Zhang</surname><given-names>J.X.</given-names></name><name><surname>Yang</surname><given-names>J.R.</given-names></name><name><surname>Su</surname><given-names>Q.</given-names></name></person-group><article-title>Sesamin ameliorates advanced glycation end products-induced pancreatic &#x003b2;-cell dysfunction and apoptosis</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>4689</fpage><lpage>4704</lpage><pub-id pub-id-type="doi">10.3390/nu7064689</pub-id><pub-id pub-id-type="pmid">26066015</pub-id></element-citation></ref><ref id="B29-molecules-25-03062"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group><article-title>Sasamin suppresses STZ induced INS-1 cell apoptosis through inhibition of NF-&#x003ba;B activation and regulation of Bcl-2 family protein expression</article-title><source>Eur. J. Pharmacol.</source><year>2015</year><volume>750</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.01.031</pub-id><pub-id pub-id-type="pmid">25637086</pub-id></element-citation></ref><ref id="B30-molecules-25-03062"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>E.C.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Su</surname><given-names>K.</given-names></name></person-group><article-title>Differential regulation of tefluthrin and telmisartan on the gating charges of <italic>I</italic><sub>Na</sub> activation and inactivation as well as on resurgent and persistent <italic>I</italic><sub>Na</sub> in a pituitary cell line (GH<sub>3</sub>)</article-title><source>Toxicol. Lett.</source><year>2018</year><volume>285</volume><fpage>104</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2018.01.002</pub-id><pub-id pub-id-type="pmid">29306026</pub-id></element-citation></ref><ref id="B31-molecules-25-03062"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.N.</given-names></name><name><surname>Wu</surname><given-names>Y.H.</given-names></name><name><surname>Chen</surname><given-names>B.S.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Liu</surname><given-names>Y.C.</given-names></name></person-group><article-title>Underlying mechanism of actions of tefluthrin, a pyrethroid insecticide, on voltage-gated ion currents and on action currents in pituitary tumor (GH<sub>3</sub>) cells and GnRH-secreting (GT1-7) neurons</article-title><source>Toxicology</source><year>2009</year><volume>258</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2009.01.009</pub-id><pub-id pub-id-type="pmid">19378468</pub-id></element-citation></ref><ref id="B32-molecules-25-03062"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Activation of voltage-gated sodium current and inhibition of <italic>erg</italic>-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>2018</year><volume>45</volume><fpage>797</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1111/1440-1681.12943</pub-id><pub-id pub-id-type="pmid">29617054</pub-id></element-citation></ref><ref id="B33-molecules-25-03062"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Liu</surname><given-names>P.Y.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Feng</surname><given-names>Y.H.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Differential inhibitory actions of multitargeted tyrosine kinase inhibitors on different ionic current types in cardiomyocytes</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1672</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21051672</pub-id><pub-id pub-id-type="pmid">32121388</pub-id></element-citation></ref><ref id="B34-molecules-25-03062"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selyanko</surname><given-names>A.A.</given-names></name><name><surname>Hadley</surname><given-names>J.K.</given-names></name><name><surname>Wood</surname><given-names>I.C.</given-names></name><name><surname>Abogadie</surname><given-names>F.C.</given-names></name><name><surname>Delmas</surname><given-names>P.</given-names></name><name><surname>Buckley</surname><given-names>N.J.</given-names></name><name><surname>London</surname><given-names>B.</given-names></name><name><surname>Brown</surname><given-names>D.A.</given-names></name></person-group><article-title>Two types of K<sup>+</sup> channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell</article-title><source>J. Neurosci.</source><year>1999</year><volume>19</volume><fpage>7742</fpage><lpage>7756</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-18-07742.1999</pub-id><pub-id pub-id-type="pmid">10479678</pub-id></element-citation></ref><ref id="B35-molecules-25-03062"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.S.</given-names></name><name><surname>Lai</surname><given-names>M.C.</given-names></name><name><surname>Liu</surname><given-names>P.Y.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Huang</surname><given-names>C.W.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Characterization of the inhibitory effect of gastrodigenin and gastodin on M-type K<sup>+</sup> currents in pituitary cells and hippocampal neurons</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>21</volume><elocation-id>117</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21010117</pub-id><pub-id pub-id-type="pmid">31877994</pub-id></element-citation></ref><ref id="B36-molecules-25-03062"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillet</surname><given-names>C.</given-names></name><name><surname>Kurth</surname><given-names>S.</given-names></name><name><surname>Kuenzel</surname><given-names>T.</given-names></name></person-group><article-title>Muscarinic modulation of M and h currents in gerbil spherical bushy cells</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0226954</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0226954</pub-id><pub-id pub-id-type="pmid">31940388</pub-id></element-citation></ref><ref id="B37-molecules-25-03062"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>H.T.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Characterization of convergent suppression by UCL-2077 (3-triphenylmethylaminomethyl)pyridine, known to inhibit slow afterhyperpolarization, of <italic>erg</italic>-mediated potassium currents and intermediate-conductance calcium-activated potassium channels</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1441</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21041441</pub-id></element-citation></ref><ref id="B38-molecules-25-03062"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P.C.</given-names></name><name><surname>Liu</surname><given-names>Y.C.</given-names></name><name><surname>Lo</surname><given-names>Y.C.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Characterization of inhibitory effectiveness in hyperpolarization-activated cation currents by a group of <italic>ent</italic>-kaurane-type diterpenoids from <italic>Croton tonkinensis</italic></article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1268</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21041268</pub-id></element-citation></ref><ref id="B39-molecules-25-03062"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>T.L.</given-names></name><name><surname>Lu</surname><given-names>T.J.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Inhibitory effective perturbations of cilobradine (DK-AH269), a blocker of HCN channels, on the amplitude and gating of both hyperpolarization-activated cation and delayed-rectifier potassium currents</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>2416</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21072416</pub-id></element-citation></ref><ref id="B40-molecules-25-03062"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>A.V.</given-names></name><name><surname>Espinosa</surname><given-names>J.L.</given-names></name><name><surname>L&#x000f3;pez-Dom&#x000ed;nguez</surname><given-names>A.M.</given-names></name><name><surname>L&#x000f3;pez-Santiago</surname><given-names>L.F.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Cota</surname><given-names>G.</given-names></name></person-group><article-title>L-type calcium channel activation up-regulates the mRNAs for two different sodium channel &#x003b1; subunits (Na<sub>v</sub>1.2 and Na<sub>v</sub>1.3) in rat pituitary GH<sub>3</sub> cells</article-title><source>Mol. Brain Res.</source><year>2003</year><volume>116</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/S0169-328X(03)00279-1</pub-id><pub-id pub-id-type="pmid">12941467</pub-id></element-citation></ref><ref id="B41-molecules-25-03062"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stojilkovic</surname><given-names>S.S.</given-names></name><name><surname>Tabak</surname><given-names>J.</given-names></name><name><surname>Bertram</surname><given-names>R.</given-names></name></person-group><article-title>Ion channels and signaling in the pituitary gland</article-title><source>Endoc. Rev.</source><year>2010</year><volume>31</volume><fpage>845</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1210/er.2010-0005</pub-id><pub-id pub-id-type="pmid">20650859</pub-id></element-citation></ref><ref id="B42-molecules-25-03062"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>H.</given-names></name></person-group><article-title>Sesamin protects SH-SY5Y cells against mechanical stretch injury and promoting cell survival</article-title><source>BMC Neurosci.</source><year>2017</year><volume>18</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1186/s12868-017-0378-8</pub-id><pub-id pub-id-type="pmid">28784087</pub-id></element-citation></ref><ref id="B43-molecules-25-03062"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussien</surname><given-names>H.M.</given-names></name><name><surname>Abdou</surname><given-names>H.M.</given-names></name><name><surname>Yousef</surname><given-names>M.</given-names></name></person-group><article-title>Cypermethrin induced damage in genomic DNA and histopathological changes in brain and haematotoxicity in rats: The protective effect of sesame oil</article-title><source>Brain Res. Bullet.</source><year>2013</year><volume>92</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.10.020</pub-id></element-citation></ref><ref id="B44-molecules-25-03062"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdou</surname><given-names>H.M.</given-names></name><name><surname>Hussien</surname><given-names>H.M.</given-names></name><name><surname>Yousef</surname><given-names>M.I.</given-names></name></person-group><article-title>Deleterious effects of cypermethrin on rat liver and kidney: Protective role of sesame oil</article-title><source>J. Environ. Sci. Health</source><year>2012</year><volume>47</volume><fpage>306</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1080/03601234.2012.640913</pub-id></element-citation></ref><ref id="B45-molecules-25-03062"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>M.M.</given-names></name><name><surname>Attia</surname><given-names>H.F.</given-names></name><name><surname>El-Ella</surname><given-names>G.A.</given-names></name></person-group><article-title>Genetic and histopathological alterations induced by cypermethrin in rat kidney and liver: Protection by sesame oil</article-title><source>Int. J. Immunopathol. Pharmacol.</source><year>2015</year><volume>28</volume><fpage>508</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1177/0394632015575950</pub-id><pub-id pub-id-type="pmid">25816392</pub-id></element-citation></ref><ref id="B46-molecules-25-03062"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Elsherbiny</surname><given-names>N.M.</given-names></name><name><surname>Haque</surname><given-names>R.</given-names></name><name><surname>Khan</surname><given-names>M.B.</given-names></name><name><surname>Ishrat</surname><given-names>T.</given-names></name><name><surname>Shah</surname><given-names>Z.A.</given-names></name><name><surname>Khan</surname><given-names>M.M.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Jamal</surname><given-names>A.</given-names></name><name><surname>Katare</surname><given-names>D.P.</given-names></name><etal/></person-group><article-title>Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke</article-title><source>Neurotoxicity</source><year>2014</year><volume>45</volume><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2014.10.002</pub-id></element-citation></ref><ref id="B47-molecules-25-03062"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Zhao</surname><given-names>T.T.</given-names></name><name><surname>Lee</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Shin</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Choi</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name></person-group><article-title>Effect of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson&#x02019;s disease rat models</article-title><source>Neurochem. Int.</source><year>2015</year><volume>83&#x02013;84</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2015.01.003</pub-id></element-citation></ref><ref id="B48-molecules-25-03062"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.L.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.B.</given-names></name><name><surname>Wang</surname><given-names>D.S.</given-names></name><name><surname>Wang</surname><given-names>X.S.</given-names></name><name><surname>Zhang</surname><given-names>Z.W.</given-names></name><name><surname>Zhao</surname><given-names>M.G.</given-names></name><name><surname>Liu</surname><given-names>S.B.</given-names></name></person-group><article-title>Anxiolytic effects of sesamin in mice with chronic inflammatory pain</article-title><source>Nutr. Neurosci.</source><year>2016</year><volume>19</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1179/1476830515Y.0000000015</pub-id><pub-id pub-id-type="pmid">25822813</pub-id></element-citation></ref><ref id="B49-molecules-25-03062"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>T.T.</given-names></name><name><surname>Shin</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>K.E.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name></person-group><article-title>Effects of (&#x02212;)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson&#x02019;s disease treated with l-DOPA</article-title><source>Neuroscience</source><year>2016</year><volume>339</volume><fpage>644</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.10.042</pub-id><pub-id pub-id-type="pmid">27789382</pub-id></element-citation></ref><ref id="B50-molecules-25-03062"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>T.T.</given-names></name><name><surname>Shin</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Yi</surname><given-names>B.R.</given-names></name><name><surname>Lee</surname><given-names>K.E.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name></person-group><article-title>Effects of (&#x02212;)-sesamin on chronic stress-induced anxiety disorders in mice</article-title><source>Neurochem. Res.</source><year>2017</year><volume>42</volume><fpage>1123</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1007/s11064-016-2146-z</pub-id><pub-id pub-id-type="pmid">27995494</pub-id></element-citation></ref><ref id="B51-molecules-25-03062"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.L.</given-names></name><name><surname>Xu</surname><given-names>Z.M.</given-names></name><name><surname>Yang</surname><given-names>G.Y.</given-names></name><name><surname>Yang</surname><given-names>D.X.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><name><surname>Tian</surname><given-names>H.L.</given-names></name></person-group><article-title>Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury</article-title><source>Acta Pharmacol. Sin.</source><year>2017</year><volume>38</volume><fpage>1445</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1038/aps.2017.103</pub-id><pub-id pub-id-type="pmid">28770828</pub-id></element-citation></ref><ref id="B52-molecules-25-03062"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farbood</surname><given-names>Y.</given-names></name><name><surname>Ghaderi</surname><given-names>S.</given-names></name><name><surname>Rashno</surname><given-names>M.</given-names></name><name><surname>Khoshnam</surname><given-names>S.E.</given-names></name><name><surname>Khorsandi</surname><given-names>L.</given-names></name><name><surname>Sarkaki</surname><given-names>A.</given-names></name><name><surname>Rashno</surname><given-names>M.</given-names></name></person-group><article-title>Sesamin: A promising protective agent against diabetes-associated cognitive decline in rats</article-title><source>Life Sci.</source><year>2019</year><volume>230</volume><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2019.05.071</pub-id><pub-id pub-id-type="pmid">31150685</pub-id></element-citation></ref><ref id="B53-molecules-25-03062"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimoyoshi</surname><given-names>S.</given-names></name><name><surname>Takemoto</surname><given-names>D.</given-names></name><name><surname>Ono</surname><given-names>Y.</given-names></name><name><surname>Kitagawa</surname><given-names>Y.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Tomono</surname><given-names>S.</given-names></name><name><surname>Unno</surname><given-names>K.</given-names></name><name><surname>Wakabayashi</surname><given-names>K.</given-names></name></person-group><article-title>Sesame lignans suppress age-related cognitive decline in senescence-accelerated mice</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>1582</elocation-id><pub-id pub-id-type="doi">10.3390/nu11071582</pub-id></element-citation></ref><ref id="B54-molecules-25-03062"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>S.M.</given-names></name><name><surname>Chaurasiya</surname><given-names>N.D.</given-names></name><name><surname>Mohamed</surname><given-names>N.M.</given-names></name><name><surname>Bayoumi</surname><given-names>S.A.L.</given-names></name><name><surname>Tekwani</surname><given-names>B.L.</given-names></name><name><surname>Ross</surname><given-names>S.A.</given-names></name></person-group><article-title>Promising selective MAO-B inhibition by sesamin, a lignan from <italic>Zanthoxylum flavum</italic> stems</article-title><source>Saudi Pharm. J.</source><year>2020</year><volume>28</volume><fpage>409</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2020.02.001</pub-id><pub-id pub-id-type="pmid">32273799</pub-id></element-citation></ref><ref id="B55-molecules-25-03062"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babaei</surname><given-names>P.</given-names></name><name><surname>Dastras</surname><given-names>A.</given-names></name><name><surname>Tehrani</surname><given-names>B.S.</given-names></name><name><surname>Pourali Roudbaneh</surname><given-names>S.</given-names></name></person-group><article-title>The effect of estrogen replacement therapy on visceral fat, serum glucose, lipid profiles and apelin level in ovariectomized rats</article-title><source>J. Menopausal. Med.</source><year>2017</year><volume>23</volume><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.6118/jmm.2017.23.3.182</pub-id><pub-id pub-id-type="pmid">29354618</pub-id></element-citation></ref><ref id="B56-molecules-25-03062"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoseini</surname><given-names>R.</given-names></name><name><surname>Damirchi</surname><given-names>A.</given-names></name><name><surname>Babaei</surname><given-names>P.</given-names></name></person-group><article-title>Vitamin D increases PPAR&#x003b3; expression and promotes beneficial effects of physical activity in metabolic syndrome</article-title><source>Nutrition</source><year>2017</year><volume>36</volume><fpage>54</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2016.06.010</pub-id><pub-id pub-id-type="pmid">28336108</pub-id></element-citation></ref><ref id="B57-molecules-25-03062"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayyahi</surname><given-names>A.</given-names></name><name><surname>Jahanshahi</surname><given-names>M.</given-names></name><name><surname>Amini</surname><given-names>H.</given-names></name><name><surname>Sepehri</surname><given-names>H.</given-names></name></person-group><article-title>Vitamin E can compensate the density of M1 receptors in the hippocampus of scopolamine-treated rats</article-title><source>Folia Neuropathol.</source><year>2018</year><volume>56</volume><fpage>215</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.5114/fn.2018.78703</pub-id><pub-id pub-id-type="pmid">30509043</pub-id></element-citation></ref><ref id="B58-molecules-25-03062"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>D.W.</given-names><suffix>Jr.</suffix></name><name><surname>Hamill</surname><given-names>O.P.</given-names></name></person-group><article-title>Simplified fast pressure-clamp technique for studying mechanically gated channels</article-title><source>Methods Enzymol.</source><year>1999</year><volume>294</volume><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">9916244</pub-id></element-citation></ref><ref id="B59-molecules-25-03062"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>I.M.</given-names></name><name><surname>Bean</surname><given-names>B.P.</given-names></name></person-group><article-title>Inactivation and recovery of sodium currents in cerebellar Purkinje neurons: Evidence for two mechanisms</article-title><source>Biophys. J.</source><year>2001</year><volume>80</volume><fpage>729</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(01)76052-3</pub-id><pub-id pub-id-type="pmid">11159440</pub-id></element-citation></ref><ref id="B60-molecules-25-03062"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaliq</surname><given-names>Z.M.</given-names></name><name><surname>Gouwens</surname><given-names>N.W.</given-names></name><name><surname>Raman</surname><given-names>I.M.</given-names></name></person-group><article-title>The contribution of resurgent sodium current to high-frequency firing in Purkinje neurons: An experimental and modeling study</article-title><source>J. Neurosci.</source><year>2003</year><volume>23</volume><fpage>4899</fpage><lpage>4912</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-12-04899.2003</pub-id><pub-id pub-id-type="pmid">12832512</pub-id></element-citation></ref><ref id="B61-molecules-25-03062"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Simulations of the cardiac action potential based on the Hodgkin-Huxley kinetics with the use of Microsoft Excel spreadsheet</article-title><source>Chin. J. Physiol.</source><year>2004</year><volume>47</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15239590</pub-id></element-citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Scheme</title><fig id="molecules-25-03062-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Effect of sesamine (SSM) on voltage-gated Na<sup>+</sup> currents (<italic>I</italic><sub>Na</sub>) in pituitary GH<sub>3</sub> cells. The whole-cell recordings were undertaken in cells bathed in Ca<sup>2+</sup>-free Tyrode&#x02019;s solution containing 10 mM tetraethylammonium chloride (TEA) and the patch pipette was filled with K<sup>+</sup>-containing solution. (<bold>A</bold>) Representative <italic>I</italic><sub>Na</sub> traces obtained in the absence (a) and presence of 3 &#x003bc;M SSM (b) or 10 &#x003bc;M SSM (c). Inset shows the voltage-clamp profile applied. (<bold>B</bold>) Concentration-dependent effects of SSM on the peak and sustained components of <italic>I</italic><sub>Na</sub>. <italic>I</italic><sub>Na</sub> was evoked by abrupt depolarization from &#x02212;80 to &#x02212;10 mV. Current amplitudes obtained during cell exposure to different concentrations (0.1&#x02013;100 &#x003bc;M) of SSM were measured at the beginning (&#x025cb;, peak <italic>I</italic><sub>Na</sub>) and end (&#x025a0;, sustained <italic>I</italic><sub>Na</sub>), evoked by depolarizing voltage. Each point presented in the figure depicts the mean &#x000b1; standard error of the mean (SEM, n = 9&#x02013;12). The values of IC<sub>50</sub> and n<sub>H</sub> for SSM-induced inhibition of sustained <italic>I</italic><sub>Na</sub> were calculated to be 0.6 &#x003bc;M and 1.2, respectively, whereas those for peak <italic>I</italic><sub>Na</sub> were 7.2 &#x003bc;M and 1.2, respectively. The vertical dashed line indicates the IC<sub>50</sub> value required for SSM-perturbed inhibition of peak or sustained <italic>I</italic><sub>Na</sub> amplitude. Of note, the SSM addition is capable of differentially and concentration-dependently decreasing the amplitude of peak and sustained <italic>I</italic><sub>Na</sub> in GH<sub>3</sub> cells, without any modifications to the Hill coefficient of the curve. (<bold>C</bold>) Time-dependent block of <italic>I</italic><sub>Na</sub> inactivation caused by SSM in GH<sub>3</sub> cells. The reciprocal of the time constant of the rate of block (i.e., &#x003c4;<sub>inact(S)</sub><sup>&#x02212;1</sup>) achieved by exponential fits of the slow component of <italic>I</italic><sub>Na</sub> inactivation (&#x003c4;<sub>inact(S)</sub>) was constructed and plotted against the different concentrations of SSM applied. Data points were well fitted to a linear regression, reflecting that SSM-perturbed blocking occurs with a molecularity of 1. (<bold>D</bold>) Average <italic>I-V</italic> relationship of peak <italic>I</italic><sub>Na</sub> achieved in the absence (&#x025a0;) and presence (&#x025cb;) of 3 &#x003bc;M SSM (mean &#x000b1; SEM; n = 8 for each point). Of note, no conceivable modification in the overall <italic>I-V</italic> relationship of peak <italic>I</italic><sub>Na</sub> in the absence and presence of SSM was demonstrated in GH<sub>3</sub> cells. The statistical analyses were made by ANOVA-2 for repeated measures, <italic>P</italic>(factor 1) &#x0003c; 0.05, <italic>P</italic>(factor 2) &#x0003c; 0.05, <italic>P</italic>(interaction) &#x0003c; 0.05, followed by Duncan&#x02019;s post hoc test, <italic>P</italic> &#x0003c; 0.05. * Significantly different from controls measured at the same level of membrane potential (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g001"/></fig><fig id="molecules-25-03062-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Comparison among the effects of SSM, SesA, SSM plus tefluthrin (Tef), and SSM plus telmisartan (Tel) on the peak amplitude of <italic>I</italic><sub>Na</sub>. Experiments were conducted to measure the <italic>I</italic><sub>Na</sub> in cells which were immersed in Ca<sup>2+</sup> Tyrode&#x02019;s solution, and once the whole-cell configuration was achieved, cells were rapidly depolarized to &#x02212;10 mV from a holding potential of &#x02212;80 mV. Current amplitude was measured at the start of a brief depolarizing pulse. (<bold>A</bold>) Representative <italic>I</italic><sub>Na</sub> traces obtained in the control (a, both sides), during cell exposure to 3 &#x003bc;M SSM (b, both sides), and then to 3 &#x003bc;M SSM plus 10 &#x003bc;M tefluthrin (left side) or 3 &#x003bc;M SSM plus 10 &#x003bc;M telmisartan (right side). The upper part denotes the voltage protocol applied. In (<bold>B</bold>), each bar represents the mean &#x000b1; SEM (n = 9). The statistical analyses were done by ANOVA-1, <italic>P</italic> &#x0003c; 0.05, followed by Duncan&#x02019;s post hoc test, <italic>P</italic> &#x0003c; 0.05. Tef: tefluthrin; Tel: telmisartan. * Significantly different from control (<italic>P</italic> &#x0003c; 0.05) and <sup>&#x02020;</sup> significantly different from the SSM (3 &#x003bc;M) alone group (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g002"/></fig><fig id="molecules-25-03062-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Concentration-dependent inhibition of peak and sustained <italic>I</italic><sub>Na</sub> by sesamolin (SesA) in GH<sub>3</sub> cells. (<bold>A</bold>) Representative <italic>I</italic><sub>Na</sub> traces obtained in the control (a), during cell exposure to 3 &#x003bc;M SesA (b) or 10 &#x003bc;M SesA and washout of the compound (d). In (<bold>B</bold>), the relations between the percentage inhibition of the peak and sustained components of <italic>I</italic><sub>Na</sub> in response to brief depolarizing pulse are illustrated. Current amplitudes measured at the beginning or end of a depolarizing step from &#x02212;80 to &#x02212;10 mV in the absence or presence of different SesA concentrations were compared with the control values. The continuous lines overlaid were reasonably fitted by a modified Hill function (see text for details). The IC<sub>50</sub> values (indicated by the vertical dashed line) needed for the inhibition of the peak (&#x025cb;) or sustained (&#x025a0;) <italic>I</italic><sub>Na</sub> in the presence of SesA were 9.8 and 2.5 &#x003bc;M, respectively.</p></caption><graphic xlink:href="molecules-25-03062-g003"/></fig><fig id="molecules-25-03062-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Inhibitory effect of SSM on resurgent <italic>I</italic><sub>Na</sub> (<italic>I</italic><sub>Na(R)</sub>) recorded from GH<sub>3</sub> cells. (<bold>A</bold>) Representative <italic>I</italic><sub>Na(R)</sub> achieved when the examined cell was depolarized from &#x02212;80 to +20 mV for 40 msec, then repolarized to various potentials ranging between &#x02212;50 and 0 mV. a: control; b: 1 &#x003bc;M SSM. (<bold>B</bold>) Average <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>Na(R)</sub> attained in the control (&#x025a0;) or during cell exposure to 1 &#x003bc;M SSM (&#x025cb;) (mean &#x000b1; SEM; n = 8 for each point). Of note, the overall <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>Na(R)</sub> remains unaltered in the presence of SSM, though this agent is able to decrease the amplitude of <italic>I</italic><sub>Na(R)</sub>. Data analyses were done by ANOVA-2 for repeated measures, <italic>P</italic>(factor 1) &#x0003c; 0.05, <italic>P</italic>(factor 2) &#x0003c; 0.05, <italic>P</italic>(interaction) &#x0003c; 0.05, followed by Duncan&#x02019;s post hoc test, <italic>P</italic> &#x0003c; 0.05. * Significantly different from controls measured at the same level of membrane potential (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g004"/></fig><fig id="molecules-25-03062-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Inhibitory effect of SSM on M-type K<sup>+</sup> currents (<italic>I</italic><sub>K(M)</sub>) in GH<sub>3</sub> cells. In these whole-cell experiments, we bathed cells in high-K<sup>+</sup>, Ca<sup>2+</sup>-free solution and the electrode was filled with K<sup>+</sup>-containing solution. (<bold>A</bold>) Original <italic>I</italic><sub>K(M)</sub> traces elicited by membrane depolarization from &#x02212;50 to &#x02212;10 mV (as indicated in the upper part). a: control; b: 1 &#x003bc;M SSM; c: 3 &#x003bc;M SSM. (<bold>B</bold>) Concentration&#x02013;response relationship for the SSM-perturbed inhibition of <italic>I</italic><sub>K(M)</sub> amplitude (mean &#x000b1; SEM; n = 8&#x02013;9 for each point). Each cell was voltage clamped at &#x02212;50 mV and was thereafter depolarized from &#x02212;50 to &#x02212;10 mV with a duration of 1 sec, and current amplitudes in different concentrations of SSM were obtained at the end of the depolarizing pulse delivered. The continuous line shows the best fit to the modified Hill equation, while the vertical dashed line indicates the IC<sub>50</sub> value.</p></caption><graphic xlink:href="molecules-25-03062-g005"/></fig><fig id="molecules-25-03062-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Inhibitory effect of SSM on <italic>erg</italic>-mediated K<sup>+</sup> currents (<italic>I</italic><sub>K(erg)</sub>) in GH<sub>3</sub> cells. Cells were immersed in high-K<sup>+</sup>, Ca<sup>2+</sup>-free solution and the recording pipette was filled up with K<sup>+</sup>-containing solution. (<bold>A</bold>) Representative <italic>I</italic><sub>K(erg)</sub> traces obtained in the control (a, SSM was not present) or during the exposure to 30 &#x003bc;M SSM. The inset in the upper part shows the voltage protocol delivered. (<bold>B</bold>) Average <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>K(erg)</sub> obtained without (&#x025a0;) or with (&#x025cb;) the addition of 30 &#x003bc;M SSM (mean &#x000b1; SEM; n = 9 for each point). Each <italic>I</italic><sub>K(erg)</sub> amplitude was measured at the beginning of a 1-sec hyperpolarization from &#x02212;10 mV to various voltages ranging between &#x02212;100 and &#x02212;10 mV in 10-mV increments. Data analyses were done by ANOVA-2 for repeated measures, <italic>P</italic>(factor 1) &#x0003c; 0.05, <italic>P</italic>(factor 2) &#x0003c; 0.05, <italic>P</italic>(interaction) &#x0003c; 0.05, followed by Duncan&#x02019;s post hoc test, <italic>P</italic> &#x0003c; 0.05. * Significantly different from controls measured at the same level of membrane potential (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g006"/></fig><fig id="molecules-25-03062-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Inhibitory effect of SSM on delayed rectifier K<sup>+</sup> currents (<italic>I</italic><sub>K(DR)</sub>) in GH<sub>3</sub> cells. The experiments were undertaken in cells bathed in Ca<sup>2+</sup>-free Tyrode&#x02019;s solution containing 1 &#x003bc;M TTX, and the recording electrode was filled with K<sup>+</sup>-containing solution. (<bold>A</bold>) Representative <italic>I</italic><sub>K(DR)</sub> traces obtained in the control (a) and during the exposure to 10 &#x003bc;M SSM. The voltage profile used is illustrated in the inset of the upper part. (<bold>B</bold>) Average <italic>I&#x02013;V</italic> relationship of <italic>I</italic><sub>K(DR)</sub> taken in the absence (&#x025a0;) or presence (&#x025cb;) or 10 &#x003bc;M SSM (mean &#x000b1; SEM; n = 8 for each point). Current amplitudes were measured at the end of each depolarizing pulse. * Significantly different from controls measured at the same level of membrane potential (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g007"/></fig><fig id="molecules-25-03062-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Failure of SSM to modify hyperpolarization-activated cation currents (<italic>I</italic><sub>h</sub>) identified in GH<sub>3</sub> cells. In this set of whole-cell current recordings, we immersed cells in Ca<sup>2+</sup>-free Tyrode&#x02019;s solution and filled up the electrode by using K<sup>+</sup>-containing solution. (<bold>A</bold>) Representative <italic>I</italic><sub>h</sub> traces obtained in the absence (a) and the presence of 10 &#x003bc;M SSM (b) or 10 &#x003bc;M SSM plus 3 &#x003bc;M cilobradine (c). The upper part shows the voltage protocol applied. (<bold>B</bold>) Bar graph showing the effect of SSM and SSM plus cilobradine (CIL) on the <italic>I</italic><sub>h</sub> amplitude in GH<sub>3</sub> cells (mean &#x000b1; SEM; n = 9 for each bar). The examined cell was 1-sec hyperpolarized from &#x02212;40 to &#x02212;110 mV and the current amplitude was taken at the end of the hyperpolarizing command step. Data analysis was done by ANOVA-1. * Significantly different from control or SSM (10 &#x003bc;M) alone (<italic>P</italic> &#x0003c; 0.05) and <sup>&#x02020;</sup> significantly different from the SSM (10 &#x003bc;M) plus cilobradine (3 &#x003bc;M) group (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="molecules-25-03062-g008"/></fig><fig id="molecules-25-03062-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Numerical simulations of the SSM-mediated inhibition of voltage-gated Na<sup>+</sup> currents (<italic>I</italic><sub>Na</sub>). The state diagram of a Markovian model for the Na<sub>V</sub> channel (i.e., <italic>SCN8A</italic> channel) depicted in (<bold>A</bold>) was adopted from a recent study [<xref rid="B42-molecules-25-03062" ref-type="bibr">42</xref>]. The solutions to the ordinary differential equations in the current study were implemented in the XPP software package, and the default values for detailed numerical parameters are identical to those demonstrated previously [<xref rid="B42-molecules-25-03062" ref-type="bibr">42</xref>], except that the values of &#x003b5; (i.e., voltage-independent transition rate from the open to blocked state) and maximal conductance of <italic>I</italic><sub>Na</sub> in the control (i.e., SSM was not present) were arbitrarily assigned to be 0.3 msec<sup>&#x02212;1</sup> and 3.6 nS, respectively. In (<bold>A</bold>), C: closed state; O: open state; OB: blocked state; I: inactivated state. Oon and Ooff represent the on and off transition rates for the normal inactivation of Na<sub>V</sub> channels from the open (O) state, respectively, and are independent of voltage, while Con and Coff are the on and off rates for normal inactivation from the C1&#x02013;C5 states and is also independent of voltage. a = (Oon/Con)<sup>1/4</sup> and b = (Ooff/Coff)<sup>1/4</sup>. In (<bold>B</bold>), the model cell was abruptly depolarized from &#x02212;80 to &#x02212;10 mV, then repolarized to -50 mV (as indicated in the inset). When the value of Oon was raised to 3.5 msec<sup>&#x02212;1</sup> (b) or 4.6 msec<sup>&#x02212;1</sup> (c) from a control value of 2.3 msec<sup>&#x02212;1</sup> (a), and the value of maximal conductance was simultaneously reduced to 2.7 nS (b) or 1.8 nS (c) from a control value of 3.6 nS (a), there was a noticeable reduction in the peak amplitude of simulated <italic>I</italic><sub>Na</sub> in combination with the slowed inactivation time constant of the current. Trace (a) is the control, and those labeled (b) and (c) were created to mimic the inhibitory effect of 0.3 and 1 &#x003bc;M SSM on <italic>I</italic><sub>Na</sub> in response to brief depolarization, respectively. (<bold>C</bold>) State probability of simulated Na<sub>V</sub> channel. The blue continuous and red dashed lines indicated in each panel denote the occupancy probability of the open (O) or blocked (OB) state of the Na<sub>V</sub> channel existing in (<bold>A</bold>), respectively. Noticeably, OB entered by the second mechanism of inactivation, which denotes that the channel is probably not blocked. Panels (Ca), (Cb), and (Cc) were achieved in the control (i.e., SSM was not present), and in the presence of 0.3 and 1 &#x003bc;M SSM. Of note, in the presence of SSM, the probability of the blocked (OB) state of the channel was suppressed to a greater extent than that in the open (O) state.</p></caption><graphic xlink:href="molecules-25-03062-g009"/></fig><fig id="molecules-25-03062-sch001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03062-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p>Simple scheme for simulation of the <italic>SCN8A</italic>-encoded channel</p></caption><graphic xlink:href="molecules-25-03062-sch001"/></fig></sec></back></article>